[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":656,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":1540},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"meta":657,"data":659},{"total":658},"233",[660,763,860,918,987,1048,1108,1204,1277,1444],{"id":661,"createTime":662,"updateTime":663,"relativeEntities":664,"slug":665,"properties":666,"entityType":673,"verifyStatus":25,"verifyTime":674,"verifyNote":675,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":676,"fullTextUrl":26,"authors":677,"publicationType":732,"publisherRelationship":733,"citationCount":36,"citationInfo":752,"publishDate":754,"publishYear":755,"citationAnalyzeStatus":756,"lastCitationAnalyze":757,"indexDatabases":26,"openAccess":26,"references":758,"isForceReanalyzing":762},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":667,"doi":669,"gsPaper":671},{"ES":668},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":670},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":672},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[678,694,706,718],{"id":679,"sortIndex":59,"researcher":26,"roles":680,"affiliations":682,"properties":691},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[681],"AUTHOR",[683],{"id":26,"sortIndex":36,"affiliation":684,"properties":26},{"id":685,"createTime":686,"updateTime":686,"relativeEntities":687,"slug":26,"properties":688,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":689},{"VI":690},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":692},{"VI":693},"S. Delplanque",{"id":695,"sortIndex":114,"researcher":26,"roles":696,"affiliations":697,"properties":703},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[681],[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":685,"createTime":686,"updateTime":686,"relativeEntities":700,"slug":26,"properties":701,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":702},{"VI":690},{"title":704},{"VI":705},"E. Declas",{"id":707,"sortIndex":115,"researcher":26,"roles":708,"affiliations":709,"properties":715},"cf770415-864d-4750-a611-abe739471221",[681],[710],{"id":26,"sortIndex":36,"affiliation":711,"properties":26},{"id":685,"createTime":686,"updateTime":686,"relativeEntities":712,"slug":26,"properties":713,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":714},{"VI":690},{"title":716},{"VI":717},"G. Giraudet",{"id":719,"sortIndex":36,"researcher":26,"roles":720,"affiliations":721,"properties":727},"08fc2047-379d-421d-a1db-869f3b3936fd",[681],[722],{"id":26,"sortIndex":36,"affiliation":723,"properties":26},{"id":685,"createTime":686,"updateTime":686,"relativeEntities":724,"slug":26,"properties":725,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":726},{"VI":690},{"title":728,"gsAuthor":730},{"VI":729},"M. Cosson",{"VOID":731},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":676,"publisher":734,"properties":747},{"id":735,"createTime":736,"updateTime":736,"relativeEntities":737,"slug":738,"properties":739,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":744,"manageAffiliations":745,"indexDatabases":746,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":740,"title":742},{"VOID":741},"1283081X",{"EN":743},"EMC - Ginecología-Obstetricia",[],[],[],{"volume":748,"pages":750},{"VOID":749},"56",{"VOID":751},"1-12",{"total":36,"publishYear":36,"statisticByYear":753},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[759],{"id":26,"text":760,"url":26,"identifiers":761},"Cosson, 2011",{},false,{"id":764,"createTime":765,"updateTime":766,"relativeEntities":767,"slug":768,"properties":769,"entityType":673,"verifyStatus":25,"verifyTime":766,"verifyNote":675,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":776,"fullTextUrl":26,"authors":777,"publicationType":732,"publisherRelationship":844,"citationCount":26,"citationInfo":26,"publishDate":858,"publishYear":859,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":762},"4342c456-c360-4277-8e2c-1649fcb7bf79","2023-12-28T12:31:07.555+00:00","2024-12-23T20:05:25.616+00:00",[],"Diagn%C3%B3stico-por-imagen-de-la-endometriosis-p%C3%A9lvica",{"references":770,"title":772,"doi":774},{"VOID":771},"Koninckx, 1991, Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain, Fertil Steril, 55, 759, 10.1016\u002FS0015-0282(16)54244-7\nThomassin, 2004, Symptoms before and after surgical removal of colorectal endometriosis that are assessed by magnetic resonance imaging and rectal endoscopic sonography, Am J Obstet Gynecol, 190, 1264, 10.1016\u002Fj.ajog.2003.12.004\nCornillie, 1990, Deeply infiltrating pelvic endometriosis: histology and clinical significance, Fertil Steril, 53, 978, 10.1016\u002FS0015-0282(16)53570-5\nBazot, 2004, Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis, Ultrasound Obstet Gynecol, 24, 180, 10.1002\u002Fuog.1108\nBazot, 2011, Learning curve of transvaginal ultrasound for the diagnosis of endometriomas assessed by the cumulative summation test (LC-CUSUM), Fertil Steril, 95, 301, 10.1016\u002Fj.fertnstert.2010.08.033\nNisolle, 1997, Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities [see comments], Fertil Steril, 68, 585, 10.1016\u002FS0015-0282(97)00191-X\nBazot, 2004, Deep pelvic endometriosis: MR imaging for diagnosis and prediction of extension of disease, Radiology, 232, 379, 10.1148\u002Fradiol.2322030762\nChapron, 2004, Accuracy of rectal endoscopic ultrasonography and magnetic resonance imaging in the diagnosis of rectal involvement for patients presenting with deeply infiltrating endometriosis, Ultrasound Obstet Gynecol, 24, 175, 10.1002\u002Fuog.1107\nKinkel, 1999, Magnetic resonance imaging characteristics of deep endometriosis, Hum Reprod, 14, 1080, 10.1093\u002Fhumrep\u002F14.4.1080\nBalleyguier, 2002, Comparison of magnetic resonance imaging and transvaginal ultrasonography in diagnosing bladder endometriosis, J Am Assoc Gynecol Laparosc, 9, 15, 10.1016\u002FS1074-3804(05)60099-0\nPiketty, 2009, Preoperative work-up for patients with deeply infiltrating endometriosis: transvaginal ultrasonography must definitely be the first-line imaging examination, Hum Reprod, 24, 602, 10.1093\u002Fhumrep\u002Fden405\nHudelist, 2009, Combination of transvaginal sonography and clinical examination for preoperative diagnosis of pelvic endometriosis, Hum Reprod, 24, 1018, 10.1093\u002Fhumrep\u002Fdep013\nGonçalves MO da C, 2010, Transvaginal ultrasonography with bowel preparation is able to predict the number of lesions and rectosigmoid layers affected in cases of deep endometriosis, defining surgical strategy, Hum Reprod, 25, 665, 10.1093\u002Fhumrep\u002Fdep433\nDessole, 2003, Sonovaginography is a new technique for assessing rectovaginal endometriosis, Fertil Steril, 79, 1023, 10.1016\u002FS0015-0282(02)04952-X\nReid, 2014, Office gel sonovaginography for the diagnosis of posterior deep infiltrating endometriosis: a multicenter prospective observational study, Ultrasound Obstet Gynecol, 44, 710, 10.1002\u002Fuog.13422\nKupfer, 1992, Transvaginal sonographic appearance of endometriomata: spectrum of findings, J Ultrasound Med, 11, 129, 10.7863\u002Fjum.1992.11.4.129\nMais, 1993, The efficiency of transvaginal ultrasonography in the diagnosis of endometrioma, Fertil Steril, 60, 776, 10.1016\u002FS0015-0282(16)56275-X\nPatel, 1999, Endometriomas: diagnostic performance of US [published erratum appears in Radiology 1999 Dec;213(3):930] [see comments], Radiology, 210, 739, 10.1148\u002Fradiology.210.3.r99fe61739\nJain, 1994, Prospective evaluation of adnexal masses with endovaginal gray-scale and duplex and color Doppler US: correlation with pathologic findings [see comments], Radiology, 191, 63, 10.1148\u002Fradiology.191.1.8134599\nGuerriero, 1998, The diagnosis of endometriomas using colour Doppler energy imaging, Hum Reprod, 13, 1691, 10.1093\u002Fhumrep\u002F13.6.1691\nValenzano Menada, 2008, Does transvaginal ultrasonography combined with water-contrast in the rectum aid in the diagnosis of rectovaginal endometriosis infiltrating the bowel?, Hum Reprod, 23, 1069, 10.1093\u002Fhumrep\u002Fden057\nPhilip, 2015, Three-dimensional (3D) rectosonography: description of a new 3D transvaginal ultrasonography technique with intrarectal contrast to assess colorectal endometriosis, Ultrasound Obstet Gynecol, 45, 233, 10.1002\u002Fuog.13446\nGuerriero, 2014, Three-dimensional ultrasonography in the diagnosis of deep endometriosis, Hum Reprod, 29, 1189, 10.1093\u002Fhumrep\u002Fdeu054\nBazot, 2011, Value of thin-section oblique axial T2-weighted magnetic resonance images to assess uterosacral ligament endometriosis, Hum Reprod, 26, 346, 10.1093\u002Fhumrep\u002Fdeq336\nBazot, 2005, Sonography and MR imaging for the assessment of deep pelvic endometriosis, J Minim Invasive Gynecol, 12, 178, 10.1016\u002Fj.jmig.2005.01.014\nTakeuchi, 2005, A novel technique using magnetic resonance imaging jelly for evaluation of rectovaginal endometriosis, Fertil Steril, 83, 442, 10.1016\u002Fj.fertnstert.2004.08.021\nTogashi, 1991, Endometrial cysts: diagnosis with MR imaging, Radiology, 180, 73, 10.1148\u002Fradiology.180.1.2052726\nGhezzi, 2005, “Kissing ovaries”: a sonographic sign of moderate to severe endometriosis, Fertil Steril, 83, 143, 10.1016\u002Fj.fertnstert.2004.05.094\nChapron, 2003, Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease, Hum Reprod, 18, 760, 10.1093\u002Fhumrep\u002Fdeg152\nDonnez, 2000, Bladder endometriosis must be considered as bladder adenomyosis, Fertil Steril, 74, 1175, 10.1016\u002FS0015-0282(00)01584-3\nAbrao, 2007, Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis, Hum Reprod, 22, 3092, 10.1093\u002Fhumrep\u002Fdem187\nTanaka, 2000, Ovarian carcinoma in patients with endometriosis: MR imaging findings, AJR Am J Roentgenol, 175, 1423, 10.2214\u002Fajr.175.5.1751423\nRousset, 2014, Bowel endometriosis: preoperative diagnostic accuracy of 3.0-T MR enterography–initial results, Radiology, 273, 117, 10.1148\u002Fradiol.14132803\nChapron, 2003, Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification, Hum Reprod, 18, 157, 10.1093\u002Fhumrep\u002Fdeg009\nFein, 1966, Vesical endometriosis: a case report and review of the literature, J Urol, 95, 45, 10.1016\u002FS0022-5347(17)63405-0\nFedele, 1998, Bladder endometriosis: deep infiltrating endometriosis or adenomyosis?, Fertil Steril, 69, 972, 10.1016\u002FS0015-0282(98)00048-X\nBazot, 2012, The value of MRI in assessing parametrial involvement in endometriosis, Hum Reprod, 27, 2352, 10.1093\u002Fhumrep\u002Fdes211\nHarada, 1992, [A case of ureteral endometriosis; the usefulness of MRI for preoperative diagnosis], Hinyokika Kiyo, 38, 207\nBazot, 2007, Accuracy of transvaginal sonography and rectal endoscopic sonography in the diagnosis of deep infiltrating endometriosis, Ultrasound Obstet Gynecol, 30, 994, 10.1002\u002Fuog.4070\nBazot, 2009, Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis, Fertil Steril, 92, 1825, 10.1016\u002Fj.fertnstert.2008.09.005\nRoseau, 2014, Recto-sigmoid endoscopic-ultrasonography in the staging of deep infiltrating endometriosis, World J Gastrointest Endosc, 6, 525, 10.4253\u002Fwjge.v6.i11.525",{"ES":773},"Diagnóstico por imagen de la endometriosis pélvica",{"VOID":775},"10.1016\u002Fs1283-081x(17)85962-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X17859622",[778,793,808,820,832],{"id":779,"sortIndex":114,"researcher":26,"roles":780,"affiliations":781,"properties":790},"42d27a1f-4443-4a85-a019-34317dae4df1",[681],[782],{"id":26,"sortIndex":36,"affiliation":783,"properties":26},{"id":784,"createTime":785,"updateTime":785,"relativeEntities":786,"slug":26,"properties":787,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e4e27a99-55e7-4114-9175-b65871a972f7","2023-12-28T12:31:07.587+00:00",[],{"title":788},{"VI":789},"Gynécologie-obstétrique et médecine de la reproduction, Hôpital Tenon, Groupe hospitalier Paris-Est, AP–HP, Université Pierre-et-Marie-Curie, 4, rue de la Chine, 75020 Paris, France",{"title":791},{"VI":792},"M.K. Ballester",{"id":794,"sortIndex":59,"researcher":26,"roles":795,"affiliations":796,"properties":805},"47c53883-ddf2-4292-b13d-d8f554dd35cc",[681],[797],{"id":26,"sortIndex":36,"affiliation":798,"properties":26},{"id":799,"createTime":800,"updateTime":800,"relativeEntities":801,"slug":26,"properties":802,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a1dbd9b0-f92c-41bd-92dd-ed0429abc926","2023-12-28T12:31:07.577+00:00",[],{"title":803},{"VI":804},"Service de radiologie, Hôpital Tenon, Groupe hospitalier Paris-Est, AP–HP, Université Pierre-et-Marie-Curie, 4, rue de la Chine, 75020 Paris, France",{"title":806},{"VI":807},"M. Bazot",{"id":809,"sortIndex":111,"researcher":26,"roles":810,"affiliations":811,"properties":817},"95e1e738-c242-4dfd-b2b4-e1d8c17dc308",[681],[812],{"id":26,"sortIndex":36,"affiliation":813,"properties":26},{"id":784,"createTime":785,"updateTime":785,"relativeEntities":814,"slug":26,"properties":815,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":816},{"VI":789},{"title":818},{"VI":819},"E. Daraï",{"id":821,"sortIndex":115,"researcher":26,"roles":822,"affiliations":823,"properties":829},"06d835e0-94f5-48f6-93e2-8dc1d8ce559b",[681],[824],{"id":26,"sortIndex":36,"affiliation":825,"properties":26},{"id":799,"createTime":800,"updateTime":800,"relativeEntities":826,"slug":26,"properties":827,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":828},{"VI":804},{"title":830},{"VI":831},"B. Fedida",{"id":833,"sortIndex":36,"researcher":26,"roles":834,"affiliations":835,"properties":841},"5b626dab-6d12-4ec9-ad55-da96c793a2c7",[681],[836],{"id":26,"sortIndex":36,"affiliation":837,"properties":26},{"id":799,"createTime":800,"updateTime":800,"relativeEntities":838,"slug":26,"properties":839,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":840},{"VI":804},{"title":842},{"VI":843},"I. Thomassin-Naggara",{"url":776,"publisher":845,"properties":853},{"id":735,"createTime":736,"updateTime":736,"relativeEntities":846,"slug":738,"properties":847,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":850,"manageAffiliations":851,"indexDatabases":852,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":848,"title":849},{"VOID":741},{"EN":743},[],[],[],{"volume":854,"pages":856},{"VOID":855},"53",{"VOID":857},"1-10","2017-09-01",2017,{"id":861,"createTime":862,"updateTime":863,"relativeEntities":864,"slug":865,"properties":866,"entityType":673,"verifyStatus":25,"verifyTime":863,"verifyNote":675,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":873,"fullTextUrl":26,"authors":874,"publicationType":732,"publisherRelationship":902,"citationCount":26,"citationInfo":26,"publishDate":916,"publishYear":917,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":762},"bf8617d8-c88d-4fe1-8e7d-1fff27d79f4e","2024-01-24T12:49:31.502+00:00","2024-12-24T07:14:34.913+00:00",[],"Tumores-de-la-vagina-y-lesiones-similares",{"references":867,"title":869,"doi":871},{"VOID":868},"Ali, 1996, Radiation alone for carcinoma of the vagina: variation in response related to the location of the primary tumor, Cancer, 77, 1934, 10.1002\u002F(SICI)1097-0142(19960501)77:9\u003C1934::AID-CNCR25>3.0.CO;2-#\n1988, Vagina, 169\nAnderson, 1985, Endodermal sinus tumors of the vagina. The role of primary chemotherapy, Cancer, 56, 1025, 10.1002\u002F1097-0142(19850901)56:5\u003C1025::AID-CNCR2820560509>3.0.CO;2-X\nAntonioli, 1980, Natural history of DES-associated genital tract lesions: cervical ectopy and cervicovaginal hood, Am j Obstet Cynecon, 137, 847, 10.1016\u002F0002-9378(80)90898-4\nAudet-Lapointe, 1990, Vaginal intraepithelial neoplasia, Gynecol Oncol, 36, 232, 10.1016\u002F0090-8258(90)90180-S\nBall, 1982, Management of primary vaginal carcinoma, Gynecol Oncol, 14, 154, 10.1016\u002F0090-8258(82)90085-3\nBenedet, 1984, Carcinoma in situ of the vagina, Am J Obstet Gynecol, 148, 695, 10.1016\u002F0002-9378(84)90776-2\nBenson, 1993, Neovaginal reconstruction with a rectus abdominis myocutaneous flap, Obstet Gynecol, 81, 871\nBornstein, 1987, Human Papillomavirus associated with vaginal intraepithelial neoplasia in women exposed to diethylstilbestrol in útero, Obstet Gynecol, 70, 75\nBrinton, 1990, Case-control study of in situ and invasive carcinoma of the vagina, Gynecol Oncol, 38, 49, 10.1016\u002F0090-8258(90)90010-I\nChyle, 1996, Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors, Int J Radiat Oncol Biol Phys, 35, 891, 10.1016\u002F0360-3016(95)02394-1\nCopeland, 1985, Sarcoma botryoides of the female genital tract, Obstet Gynecol, 66, 262\nCurtin, 1995, Soft-tissue sarcoma of the vagina and vulva: a clinico-pathologic study, Obstet Gynecol, 86, 269, 10.1016\u002F0029-7844(95)00160-S\nDaly, 1980, Treatment of vaginal dysplasía and carcinoma in situ with topical 5-fluro-uracil, Obstet Gynecol, 55, 350, 10.1097\u002F00006250-198003000-00016\nDancuart, 1988, Primary squamous cell carcinoma of the vagina treated by radiotherapy: a failure analysis. The MD Anderson Hospital experience 1955–1982, Int I Radiat Oncol Biol Phys, 14, 745, 10.1016\u002F0360-3016(88)90097-1\nDargent, 1992, Reconstruction du vagin aprés les opérations radicales et supraradicales, Can Oncol, 1, 35\nDavis, 1991, Invasive vaginal carcinoma: analysis of early-stage disease, Gynecol Oncol, 42, 131, 10.1016\u002F0090-8258(91)90332-Y\nDavos, 1976, Sarcoma of the vagina, Obstet Gynecol, 47, 342\nDi Saïa, 1996, Tumors of the vagina\nDixit, 1993, Squamous cell carcinoma of the vagina, Gynecol Oncol, 48, 80, 10.1006\u002Fgyno.1993.1013\nDzikonski, 1979, Gartner's duct carcinoma of vagina in pregnancy, Zentralbl Gynaecol, 101, 1595\nEddy, 1991, Underwood PD. Primary invasive vaginal carcinoma, Am J Obstet Gynecol, 165, 292, 10.1016\u002F0002-9378(91)90081-2\nElliott, 1967, Pseudo-sarcoma botryoides of cervix and vagina in pregnancy, J Obstet Gynaecol Br Commonw, 74, 728, 10.1111\u002Fj.1471-0528.1967.tb03787.x\nGerbaulet, 1993, L'adénocarcinome á cellules claires du col et du vagin de la jeune filie : DES syndrome. Possibilité de traitement conservateur, Bull Cancer\u002FRadiother, 80, 291\nGerbaulet, 1989, Conservative treatment for lower gynecological tract malignancies in children and adolescents: the institut Gustave Roussy's experience, Int J Radiat Oncol Biol Phys, 17, 655, 10.1016\u002F0360-3016(89)90119-3\nHarwood, 1982, Radiotherapy for mucosal melanomas, Int J Radiat Oncol Biol Phys, 8, 1121, 10.1016\u002F0360-3016(82)90058-X\nHays, 1988, Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents, Cancer, 61, 1893, 10.1002\u002F1097-0142(19880501)61:9\u003C1893::AID-CNCR2820610929>3.0.CO;2-9\nHerbst, 1990, Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol, Semin Surg Oncol, 6, 343, 10.1002\u002Fssu.2980060609\nHerbst, 1977, Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix, Am J Obstet Gynecol, 128, 43, 10.1016\u002F0002-9378(77)90293-9\nHerbst, 1979, An analysísof 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival, Gynecol Oncol, 7, 111, 10.1016\u002F0090-8258(79)90087-8\nHerbst, 1971, Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women, N Engl J Med, 284, 878, 10.1056\u002FNEJM197104222841604\nHilgers, 1975, Pelvicexenteration forvaginal embryonal rhabdomyosarcoma: a review, Obstet Gynecol, 45, 175\nHoffman, 1992, Upper vaginectomy for in situ and occult, superficially invasive carcinoma of the vagina, Am J Obstet Gynecol, 166, 30, 10.1016\u002F0002-9378(92)91823-S\nIkenberg, 1990, Human Papillomavirus DNA ín invasive carcinoma of the vagina, Obstet Gynecol, 76, 432\nImrie, 1986, Intraepithelial neoplasia arising in an artificial vagina, Br J Obstet Cynaecol, 93, 886, 10.1111\u002Fj.1471-0528.1986.tb08000.x\nJobson, 1983, Treatment of vaginal intraepithelial neoplasia with the carbon dioxide, Obstet Gynecol, 62, 90\nJones, 1987, Clear-cell adenocarcinoma of the lower genital tract: Memorial Hospital 1974–1984, Obstet Gynecol, 70, 573\njoseph, 1992, Small cell neuroendocrine carcinoma of the vagina, Cancer, 70, 784, 10.1002\u002F1097-0142(19920815)70:4\u003C784::AID-CNCR2820700412>3.0.CO;2-0\nKaufman, 1989, Cystic tumors\nKirkbride, 1995, Carcinoma of the vagina: experience at the Princess Margaret Hospital (1974–1989) [review], Gynecol Oncol, 56, 435, 10.1006\u002Fgyno.1995.1077\nKottmeier, 1963, The classification and clinical staging of carcinoma of the uterus and vagina, J Int Fed Gynecol Obstet, 1, 83\nKucera, 1991, Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival, Gynecol Oncol, 40, 12, 10.1016\u002F0090-8258(91)90076-H\nKurman, 1992, Tumors of the vagin\nLee, 1994, Radiotherapy alone for carcinoma of the vagina: the importance of overall treatment time, Int J Radiat Oncol Biol Phys, 29, 983, 10.1016\u002F0360-3016(94)90392-1\nLefranc, 1988, Cancer invasif sur épithélium néoformé aprés clivage recto-vaginal pour absence congénitale de vagin. Étude anatomo-clinique, virologique et thérapeutique, Gynécologie, 39, 477\nLenehan, 1986, Vaginal intraepithelial neoplasia: biologic aspects and management, Obstet Gynecol, 68, 333, 10.1097\u002F00006250-198609000-00008\nLeung, 1993, Radical radiation therapy for carcinoma of the vagina-impact of treatment modalities on outcome: Peter MacCallum Cancer Institute experience 1970–1990, Int J Radiat Oncol Biol Phys, 25, 413, 10.1016\u002F0360-3016(93)90061-Y\nLeverger, 1983, Tumeurs du sac vitellin de localisation vaginale chez l'enfant, Arch Fr Pédiatr, 40, 85\nMalkasian, 1963, Primary leiomyosarcoma of the vagina: a study of 8 cases, Am J Obstet Gynecol, 86, 730, 10.1016\u002FS0002-9378(16)35186-9\nMerino, 1991, Vaginal Cancer: the role of infectious and environmental factors, Am J Obstet Gynecol, 165, 1255, 10.1016\u002FS0002-9378(12)90738-3\nMunkarah, 1994, Mucinous adenocarcinoma arising in a neo-vagina, Gynecol Oncol, 52, 272, 10.1006\u002Fgyno.1994.1045\nNanavati, 1993, High-dose rate brachytherapy in primary stage I and II vaginal Cancer, Gynecol Oncol, 51, 67, 10.1006\u002Fgyno.1993.1248\nNoller, 1983, Maturation of vaginal and cervical epithelium in women exposed in utero to diethylstilbestrol (DESAD project), Am J Obstet Gynecol, 146, 279, 10.1016\u002F0002-9378(83)90749-4\nPastogi, 1984, Primary leiomysarcoma of the vagina: a study of five cases, Gynecol Oncol, 18, 77, 10.1016\u002F0090-8258(84)90009-X\nPerez, 1982, Long-term follow-up in radiation therapy of carcinoma of the vagina, Cancer, 49, 1308, 10.1002\u002F1097-0142(19820315)49:6\u003C1308::AID-CNCR2820490639>3.0.CO;2-G\nPerez, 1998, Vagina, 1891\nPerez, 1999, Factors affecting long-term outcome of irradiation in carcinoma of the vagina, Int J Radiat Oncol Biol Phys, 44, 37, 10.1016\u002FS0360-3016(98)00530-6\nPerren, 1992, Lymphomas of the cervix and upper vagina: a report of fíve cases and review of the literature, Gynecol Oncol, 44, 87, 10.1016\u002F0090-8258(92)90018-E\nPfister, 1996, The role of human Papillomavirus in anogenital Cancer, Obstet Gynecol Clin Nonth Am, 23, 579\nPiver, 1979, Postirradiation squamous cell carcinoma in situ of the vagina: treatment by topical 20 % 5-flurouracil cream, Am J Obstet Gynecol, 135, 377, 10.1016\u002F0002-9378(79)90709-9\nPiver, 1988, Long-term follow-up and complications of infants with vulvovaginal embryonal rhabdomyosarcoma treated with surgery, radiation therapy, and chemotherapy, Obstet Gynecol, 71, 435\nPlenti, 1971, Lymphatic system of the female genitalia\nProppe, 1984, Postoperative spindle cell nodules of genitourinary tract resembling sarcomas: a report of eight cases, Am J Surg Pathol, 8, 101, 10.1097\u002F00000478-198402000-00003\nRagnarsson-Olding, 1993, Malignant melanoma of the vagina, Cancer, 71, 1893, 10.1002\u002F1097-0142(19930301)71:5\u003C1893::AID-CNCR2820710528>3.0.CO;2-7\nRagni, 1974, Primary malignant melanoma of the vagina and vulva, Obstet Gynecol, 43, 658\nRaney, 1990, Primary chemotherapy with or without radiation therapy and\u002For surgery for children with localized sarcoma of the bladder prostate vagina uterus and cervix: a comparison of the results in intergroup rhabdomyosarcoma studies I and II, Cancer, 66, 2072, 10.1002\u002F1097-0142(19901115)66:10\u003C2072::AID-CNCR2820661006>3.0.CO;2-9\nReddy, 1991, Results ofradiotherapeutic management of primary carcinoma of the vagina, Int J Radiat Oncol Biol Phys, 21, 1041, 10.1016\u002F0360-3016(91)90747-R\nRichart, 1986, The incidence of cervical and vaginal dysplasia after exposure to DES, JAMA, 255, 36, 10.1001\u002Fjama.1986.03370010038013\nRobboy, 1986, Vaginal adenosis prior to the DES era, Hum Pathol, 17, 488, 10.1016\u002FS0046-8177(86)80039-9\nRobboy, 1984, Increased incidence of cervical et vaginal dysplasia in 3 980 diethylstilbestrol-exposed young women: experience of the National Collaboration diethylstilbestrol adenosis project, JAMA, 252, 2979, 10.1001\u002Fjama.1984.03350210027024\nRobboy, 1981, Role of hormones including DES in the pathogenesis of cervical and vaginal intra-epithelial neoplasia, Gynecol Oncol, 12, S98, 10.1016\u002F0090-8258(81)90065-2\nRobboy, 1981, Dysplasia and cytologic findings in 4.589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project, Am J Obstet Gynecol, 140, 579, 10.1016\u002F0002-9378(81)90236-2\nRobboy, 1984, Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring, Cancer, 54, 869, 10.1002\u002F1097-0142(19840901)54:5\u003C869::AID-CNCR2820540519>3.0.CO;2-I\nSandberg, 1980, Diethylstilbestrol-exposed monozygot twins discordant for cervicovaginal clear cell carcinoma, Am J Obstet Gynecol, 137, 220, 10.1016\u002F0002-9378(80)90778-4\nScheider, 1987, Multifocal squamous neoplasia of the female genital tract: significance of human Papillomavirus infection of the vagina after hysterectomy, Obstet Gynecol, 70, 292\nSedlacek, 1990, Vaginal and vulvar adenosis. An unsuspected side effect of CO2 laser vaporization, J Reprod Med, 35, 995\nSenekjian, 1987, Local therapy in stage I clear cell adenocarcinoma of the vagina, Cancer, 60, 1319, 10.1002\u002F1097-0142(19870915)60:6\u003C1319::AID-CNCR2820600626>3.0.CO;2-H\nSenekjian, 1989, Pelvic exenteration in clear cell adenocarcinoma of the vaginal and cervix, Gynecol Oncol, 34, 413, 10.1016\u002F0090-8258(89)90183-2\nSenekjian, 1988, An evaluation of stage II vaginal clear cell adenocarcinoma according to substages, Gynecol Oncol, 31, 56, 10.1016\u002F0090-8258(88)90269-7\nSillman, 1985, A review of lower genital intraepithelial neoplasia and the use of topical 5-fluo-rouracil, Obstet Gynecol Surv, 40, 190, 10.1097\u002F00006254-198504000-00002\nStock, 1995, A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities, Gynecol Oncol, 56, 45, 10.1006\u002Fgyno.1995.1008\nStock, 1992, The importance of brachytherapy technique in the management of primary carcinoma of the vagina, Int J Radiat Oncol Biol Phys, 24, 747, 10.1016\u002F0360-3016(92)90724-V\nStuart, 1988, Laser vaporization of vaginal intraepithelial neoplasia, Am J Obstet Gynecol, 158, 240, 10.1016\u002F0002-9378(88)90130-5\nSugase, 1997, Distinct manifestations of human Papillomavirus in the vagina, Int J Cancer, 72, 412, 10.1002\u002F(SICI)1097-0215(19970729)72:3\u003C412::AID-IJC7>3.0.CO;2-S\nTavassoli, 1979, Smouth muscle tumors of the vagina, Obstet Gynecol, 53, 689\nThigpen, 1986, Phase II trial of cisplatin in advanced or recurrent Cancer of the vagina: a gynecologic oncology group study, Gynecol Oncol, 23, 101, 10.1016\u002F0090-8258(86)90121-6\nTownsend, 1982, Treatment of vaginal carcinoma in situ with the carbon dioxide láser, Am J Obstet Gynecol, 143, 565, 10.1016\u002F0002-9378(82)90548-8\nTurner-Warwick, 1990, The construction and reconstruction of the vaginal with the colocecum, Surg Gynecol Obstet, 170, 132\nVan Nostrand, 1994, Primary vaginal melanoma: improved survival with radical pelvic surgery, Gynecol Oncol, 55, 234, 10.1006\u002Fgyno.1994.1283\nWelch, 1985, Pathology of colposcopic findings in 2 635 diethylstilbestrol exposed young women, Gynecol Oncol, 21, 277, 10.1016\u002F0090-8258(85)90264-1\nWright, 1992, Intraepithelial neoplasia of the lower female genital tract: etiology investigation and management, Semin Surg Oncol, 8, 180, 10.1002\u002Fssu.2980080403\nYoung, 1984, Endodermal sinus tumor of the vagina: a report of nine cases and review of the literature, Gynecol Oncol, 18, 380, 10.1016\u002F0090-8258(84)90050-7\nZaino, 1994, Diseases of the vagina\nZurhausen, 1995, Are human Papillomavirus infections not necessary or sufficient causal factors for invasive Cancer of the cervix, Int J Cancer, 63, 315, 10.1002\u002Fijc.2910630228",{"ES":870},"Tumores de la vagina y lesiones similares",{"VOID":872},"10.1016\u002Fs1283-081x(01)71891-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X01718917",[875,890],{"id":876,"sortIndex":115,"researcher":26,"roles":877,"affiliations":878,"properties":887},"fb94b185-5214-40e6-8111-62894030b407",[681],[879],{"id":26,"sortIndex":36,"affiliation":880,"properties":26},{"id":881,"createTime":882,"updateTime":882,"relativeEntities":883,"slug":26,"properties":884,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a3e5192d-ff1d-41aa-9060-8d8c7b3d9b40","2024-01-04T16:47:54.677+00:00",[],{"title":885},{"VI":886},"Service d'oncologie-radiothérapie, centre des tumeurs, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France",{"title":888},{"VI":889},"E. Deniaud-Alexandre",{"id":891,"sortIndex":36,"researcher":26,"roles":892,"affiliations":893,"properties":899},"3f864368-9a9b-4a8d-b580-cde769d3f09a",[681],[894],{"id":26,"sortIndex":36,"affiliation":895,"properties":26},{"id":881,"createTime":882,"updateTime":882,"relativeEntities":896,"slug":26,"properties":897,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":898},{"VI":886},{"title":900},{"VI":901},"E. Touboul",{"url":873,"publisher":903,"properties":911},{"id":735,"createTime":736,"updateTime":736,"relativeEntities":904,"slug":738,"properties":905,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":908,"manageAffiliations":909,"indexDatabases":910,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":906,"title":907},{"VOID":741},{"EN":743},[],[],[],{"volume":912,"pages":914},{"VOID":913},"37",{"VOID":915},"1-14","2001-01-01",2001,{"id":919,"createTime":920,"updateTime":921,"relativeEntities":922,"slug":923,"properties":924,"entityType":673,"verifyStatus":25,"verifyTime":921,"verifyNote":675,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":930,"fullTextUrl":26,"authors":931,"publicationType":732,"publisherRelationship":971,"citationCount":26,"citationInfo":26,"publishDate":985,"publishYear":986,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":762},"b54e748e-4493-4a03-a116-a214102ba6e1","2024-01-03T17:56:22.307+00:00","2025-01-24T03:28:32.126+00:00",[],"Menopausia",{"references":925,"title":927,"doi":928},{"VOID":926},"Netter, 1979, Menstruations post ménopausiques, 243\nAssociation Française pour l’Etude de la Ménopause (AFEM). La ménopause et son traitement. Brochure patiente; 2006. Disponible sur htpp:\u002F\u002Fwww.menopauseafem.com.\nGroupe d’Etude de la Ménopause et du Vieillissement. Fiche d’information aux patientes; 2013. Disponible sur htpp:\u002F\u002Fwww.gemvi.org.\nGillet JY. Ménopause. EMC (Elsevier Masson SAS, Paris), Gynécologie, 38-A-10, 1985.\nHemsell, 1974, Plasma precursors of oestrogen. correlation of the extent of conversion of plasma androstenedione to estrone with age, J Clin Endocrinol Metab, 38, 476, 10.1210\u002Fjcem-38-3-476\nGreendale, 1998, Symptom relief and side effects of postmenopausal hormones: results from the postmenopausal estrogen\u002Fprogestin interventions trial, Obstet Gynecol, 92, 982, 10.1016\u002FS0029-7844(98)00305-6\nGuthrie, 2005, Hot flushes during the menopause transition: a longitudinal study in Australian-born women, Menopause, 12, 460, 10.1097\u002F01.GME.0000155200.80687.BE\nMeriggliola, 2012, Menopause affects pain depending on pain type and characteristics, Menopause, 19, 517, 10.1097\u002Fgme.0b013e318240fe3d\nMagliano, 2010, Menopausal arthralgia: Fact or fiction, Maturitas, 67, 29, 10.1016\u002Fj.maturitas.2010.04.009\nRozenbaum H. Traitement Hormonal Substitutif. Ménopaurama AFEM 2003. Disponible sur htpp:\u002F\u002Fwww.menopauseafem.com.\nAFSSAPS. Mise au point actualisée sur le traitement hormonal de la ménopause (THM) 2006. Disponible sur http:\u002F\u002Fwww.afssaps.santé.fr.\nStrudee, 2011, Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health, Climacteric, 14, 302, 10.3109\u002F13697137.2011.570590\nGass, 2012, The 2012 hormone therapy position statement of The North American Menopause Society, Menopause, 19, 257, 10.1097\u002Fgme.0b013e31824b970a\nMaclennan, 2004, Oral oestrogen replacement therapy versus placebo for hot flushes, Cochrane Database Syst Rev, CD002978\nThe Writing Group For The Pepi Trial, 1996, Effects of hormone therapy on bone mineral density: results from the Postmenopausal estrogen\u002FProgestin Interventions trial, JAMA, 276, 1389, 10.1001\u002Fjama.1996.03540170033029\nHulleyu, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary disease in postmenopausal women (HERS I), JAMA, 280, 605, 10.1001\u002Fjama.280.7.605\nWriting Group For The Women's Health Initiative Investigators, 2002, Risks and benefits of estrogen plus progestin in healthy post menopausal women, JAMA, 288, 321, 10.1001\u002Fjama.288.3.321\nNathorst-Böös, 1993, Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women, Acta Obstet Gynecol Scand, 72, 656, 10.3109\u002F00016349309021160\nLetombe B. Ménopause et sexualité. Résumé du congrès CNGOF, 2012.\nGem, 2011, Recommandations sur le traitement médicamenteux de l’ostéoporose post-ménopausique\nAnderson, 2004, Effects of conjugated equine estrogen in post menopausal women with hysterectomy: the Women's Health Initiative Randomized Trial, JAMA, 291, 1701, 10.1001\u002Fjama.291.14.1701\nCollaborative Group On Hormonal Factors In Breast Cancer, 1997, Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer, Lancet, 350, 1047, 10.1016\u002FS0140-6736(97)08233-0\nStefanick, 2006, Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy, JAMA, 295, 1647, 10.1001\u002Fjama.295.14.1647\nLacroix, 2011, WHI Investigators. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial, JAMA, 305, 1305, 10.1001\u002Fjama.2011.382\nChlebowski, 2010, Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women, JAMA, 304, 1684, 10.1001\u002Fjama.2010.1500\nMillion Women Study Collaborators, 2003, Breast cancer and hormone replacement therapy in the Million Women Study, Lancet, 362, 419, 10.1016\u002FS0140-6736(03)14065-2\nEspié, 2007, Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase, Gynecol endocrinol, 23, 391, 10.1080\u002F09513590701382104\nFournier, 2008, Unequal risks for breast cancer associated with different hormone replacement therapies: results from E3N cohort study, Breast Cancer Res Treat, 107, 103, 10.1007\u002Fs10549-007-9523-x\nShapiro, 2011, Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: Part 1. The Collaborative Reanalysis, J Fam Plann Reprod Health Care, 37, 103, 10.1136\u002Fjfprhc.2011.0078\nShapiro, 2011, Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 2. The Women's Health Initiative: estrogen plus progestogen, J Fam Plann Reprod Health Care, 37, 165, 10.1136\u002Fjfprhc-2011-0090\nShapiro, 2011, Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3. The Women's Health Initiative: unopposed estrogen, J Fam Plann Reprod Health Care, 37, 225, 10.1136\u002Fjfprhc-2011-0091\nShapiro, 2012, Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies. Part 4: the Million Women Study, J Fam Plann Reprod Health Care, 38, 102, 10.1136\u002Fjfprhc-2011-100229\nPrentice, 2008, Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative Clinical Trial and Observational Study, Am J Epidemiol, 167, 1407, 10.1093\u002Faje\u002Fkwn090\nFournier, 2009, Estrogen-progestogen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?, J Clin Oncol, 27, 5138, 10.1200\u002FJCO.2008.21.6432\nBeral, 2011, Breast cancer risk in relation to the interval between menopause and starting hormone therapy, J Natl Cancer Inst, 103, 296, 10.1093\u002Fjnci\u002Fdjq527\nAFEM. Recommandation AFEM. février 2007. Disponible sur htpp:\u002F\u002Fwww.menopauseafem.com.\nGrady, 2002, Cardiovascular disease outcomes during 6,8 years of hormone therapy (HERS II), JAMA, 288, 49, 10.1001\u002Fjama.288.1.49\nPrentice, 2006, Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease, Am J Epidemiol, 163, 589, 10.1093\u002Faje\u002Fkwj079\nBath, 2005, Association between hormone replacement therapy and subsequent stroke: a meta-analysis, Br Med J, 330, 342, 10.1136\u002Fbmj.38331.655347.8F\nRossouw, 2007, Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause, JAMA, 297, 1465, 10.1001\u002Fjama.297.13.1465\nRenoux, 2010, Transdermel and oral hormone replacement therapy and the risk of stroke: a nested case-control study, Br Med J, 340, c2519, 10.1136\u002Fbmj.c2519\nMendelsohn, 2005, Molecular and cellular basis of cardiovascular gender differences, Science, 308, 1583, 10.1126\u002Fscience.1112062\nLobo, 2011, Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women: a hypothetical explanation, Menopause, 18, 237, 10.1097\u002Fgme.0b013e3181e9e538\nSimoncini, 2006, Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells, Fertil Steril, 86, 1235, 10.1016\u002Fj.fertnstert.2006.05.018\nMiller, 2008, Baseline characteristics of women enrolled in the Kronos early estrogen Prevention Study (KEEPS), Climateric, 11, 8\nJoann, 2013, The Kronos Early Estrogen Prevention, Women's health, 9, 9, 10.2217\u002Fwhe.12.69\nKeeps results give insight into hormone therapy. http:\u002F\u002Fwww.menopause.org\u002Fannual-meetings\u002F2012-meeting\u002Fkeeps-report.\nde Villiers, 2013, Global consensus statement on menopausal hormone therapy, Climateric, 16, 203, 10.3109\u002F13697137.2013.771520\nKanaya, 2003, Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen\u002Fprogestin Replacement Study. A randomized, double-blind, placebo controlled trial, Ann Intern Med, 138, 1, 10.7326\u002F0003-4819-138-1-200301070-00005\nMargolis, 2004, Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial, Diabetologia, 47, 1175, 10.1007\u002Fs00125-004-1448-x\nDe Lauzon-Guillain, 2009, Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l’Education Nationale (E3N) cohort, Diabetologia, 52, 2092, 10.1007\u002Fs00125-009-1456-y\nRylance, 1985, Natural progesterone and antihypertensive action, Br Med J, 290, 13, 10.1136\u002Fbmj.290.6461.13\nLee, 2011, Effects of hormone therapy on ambulatory blood pressure in postmenopausal Korean women, Climacteric, 14, 92, 10.3109\u002F13697137.2010.491924\nScarabin, 2003, Differential association of oral and transdermal œstrogen-replacement therapy with venous thromboembolism risk, Lancet, 362, 428, 10.1016\u002FS0140-6736(03)14066-4\nCanonico, 2007, Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestens, Circulation, 115, 840, 10.1161\u002FCIRCULATIONAHA.106.642280\nSanten, 2010, Postmenopausal hormone therapy: an Endocrine Society scientific statement, J Clin Endocrinol Metab, 95, 1, 10.1210\u002Fjc.2009-2509\nHerrington, 2002, Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease, Arterioscler Thromb Vasc Biol, 22, 1012, 10.1161\u002F01.ATV.0000018301.91721.94\nCanonico, 2006, Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration, J Thromb Haemost, 4, 1259, 10.1111\u002Fj.1538-7836.2006.01933.x\nOlié, 2011, Hormone therapy and recurrence of venous thromboembolism among postmenopausal women, Menopause, 18, 488, 10.1097\u002Fgme.0b013e3181f9f7c3\nGrady, 1995, Hormone replacement therapy and endometrial cancer risk: a meta-analysis, Obstet Gynecol, 85, 304, 10.1016\u002F0029-7844(94)00383-O\nBeresford, 1997, Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women, Lancet, 349, 458, 10.1016\u002FS0140-6736(96)07365-5\nAllen, 2010, Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition, Am J Epidemiol, 172, 1394, 10.1093\u002Faje\u002Fkwq300\nSomboonporn, 2011, Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis, Menopause, 18, 1060, 10.1097\u002Fgme.0b013e31821606c5\nLacey, 2006, Menopausal hormone therapy and ovarian cancer risk in the National institutes of Health-AARP Diet and Health Study Cohort, J Natl Cancer Inst, 98, 1397, 10.1093\u002Fjnci\u002Fdjj375\nLacey, 2002, Menopausal hormone replacement therapy and risk of ovarian cancer, JAMA, 288, 334, 10.1001\u002Fjama.288.3.334\nGreen, 2012, Menopausal hormone therapy and risk of gastrointestinal cancer: nested case control study within a prospective cohort, and meta-analysis, Int J Cancer, 30, 2387, 10.1002\u002Fijc.26236\nLin, 2012, The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer, Int J Cancer, 130, 419430, 10.1002\u002Fijc.26026\nMorois, 2012, Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?, Eur J Epidemiol, 27, 439, 10.1007\u002Fs10654-012-9694-6\nHogervorste, 2000, The nature of the effect of female gonadal hormone replacement therapy on cognitive function in postmenopausal women: a meta-analysis, Neuroscience, 101, 485, 10.1016\u002FS0306-4522(00)00410-3\nLeblanc, 2002, Hormone replacement therapy and cognition, Syst Evid Rev\nRoberts, 2006, Postmenopausal estrogen therapy, et alzheimer disease: overall negative findings, Alzheimer Dis Assoc Disord, 20, 141, 10.1097\u002F00002093-200607000-00004\nHenderson, 2006, Estrogen-containing hormone therapy, et alzheimer's disease risk: understanding discrepant inferences from observational and experimental research, Neuroscience, 138, 1031, 10.1016\u002Fj.neuroscience.2005.06.017\nTamborini, 2012, Ménopause et THM : ou en est-on dix ans après la WHI, Real Gynecol Obstet\nHammar, 1998, A double-blind, randomised trial comparing the effect of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms, Br J Obstet gynecol, 105, 904, 10.1111\u002Fj.1471-0528.1998.tb10237.x\nRoux, 2000, Tibolone and cc E2\u002FNETA are effective in the prevention of postmenopausal bone loss, Maturitas, 35\nSismondi, 2011, Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients-data from LIBERATE trial, Maturitas, 70, 365, 10.1016\u002Fj.maturitas.2011.09.003\nHitchcock, 2012, Oral micronized progesterone for vasomotor symptoms: a placebo-controlled randomized trial in healthy postmenopausal women, Menopause, 19, 886, 10.1097\u002Fgme.0b013e318247f07a\nNelson, 2006, Nonhormonal therapies for menopausal hot flushes. Systematic review and meta-analysis, JAMA, 295, 2057, 10.1001\u002Fjama.295.17.2057\nCarpenter, 2012, Effect of escitalopram on hot flash interference: a randomized, controlled trial, Fertil Steril, 97, 1399, 10.1016\u002Fj.fertnstert.2012.03.001\nRoueche, 1991, Abufene 400 mg et bouffées de chaleur. Etude en double aveugle versus placebo, Rev Prat Med Gen, 5, 2385\nTaylor, 2012, Complementary and alternative medicine preparations used to treat symptoms of menopause, Menopausal Med, 22\nBolanos, 2010, Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis, Menopause, 17, 660, 10.1097\u002Fgme.0b013e3181cb4fb5\nLethaby, 2007, Phytoestrogens for vasomotor menopausal symptoms, Cochrane Database Syst Rev, CD001395\nHirata, 1997, Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial, Fertil Steril, 68, 981, 10.1016\u002FS0015-0282(97)00397-X\nWiklund, 1999, Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group, Int J Clin Pharmacol Res, 19, 89\nBordet, 2008, Treating hot flushes in menopausal women with homeopathic treatment - results of an observational study, Homeopathy, 97, 10, 10.1016\u002Fj.homp.2007.11.005\nMartino, 2004, CORE Investigators. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene, J Natl Cancer Inst, 96, 1751, 10.1093\u002Fjnci\u002Fdjh319\nEttinger, 1999, Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomized clinical trial, JAMA, 282, 637, 10.1001\u002Fjama.282.7.637\nTremollieres, 2001, Les alternatives du traitement hormonal dans la prévention de l’ostéoporose : les bisphosphonates, Gynecol Obstet Fertil, 29, 846, 10.1016\u002FS1297-9589(01)00230-2\nGroup, 2008, Annual zoledronic acid for osteoporosis, Drug Ther Bull, 46, 93\nHAS. Avis de la Comission de transparence sur le Protelos. Septembre 2011. Disponible sur http:\u002F\u002F.has-sante.fr.\nHuang, 2010, An intensive. behavioural weight loss intervention and hot flushes in women, Arch Intern Med, 27, 170\nHAS. Avis de la Commission de Transparence sur le Denosumab. Décembre 2011. Disponible sur htpp:\u002F\u002Fwww.has-sante.fr.\nCummings, 2009, Denosumab for prevention of fractures in postmenopausal women with osteoporosis. FREEDOM Trial, N Engl J Med, 361, 756, 10.1056\u002FNEJMoa0809493",{"ES":923},{"VOID":929},"10.1016\u002Fs1283-081x(15)72832-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X15728328",[932,947,959],{"id":933,"sortIndex":36,"researcher":26,"roles":934,"affiliations":935,"properties":944},"e58375c9-cdee-4c69-97aa-cea12cbfdfe9",[681],[936],{"id":26,"sortIndex":36,"affiliation":937,"properties":26},{"id":938,"createTime":939,"updateTime":939,"relativeEntities":940,"slug":26,"properties":941,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7196bfd0-7a03-45f7-9e5d-f49c41e90821","2024-01-03T17:56:22.313+00:00",[],{"title":942},{"VI":943},"Service de Gynécologie et Médecine du couple, Hôpital Jeanne-de-Flandre, CHRU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":945},{"VI":946},"H. Baffet",{"id":948,"sortIndex":115,"researcher":26,"roles":949,"affiliations":950,"properties":956},"e9005ce9-a9bb-4cfb-9a29-004183354a74",[681],[951],{"id":26,"sortIndex":36,"affiliation":952,"properties":26},{"id":938,"createTime":939,"updateTime":939,"relativeEntities":953,"slug":26,"properties":954,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":955},{"VI":943},{"title":957},{"VI":958},"G. Robin",{"id":960,"sortIndex":114,"researcher":26,"roles":961,"affiliations":962,"properties":968},"74a5970d-a5d8-40d0-810b-6bee9d1a6ad7",[681],[963],{"id":26,"sortIndex":36,"affiliation":964,"properties":26},{"id":938,"createTime":939,"updateTime":939,"relativeEntities":965,"slug":26,"properties":966,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":967},{"VI":943},{"title":969},{"VI":970},"B. Letombe",{"url":930,"publisher":972,"properties":980},{"id":735,"createTime":736,"updateTime":736,"relativeEntities":973,"slug":738,"properties":974,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":977,"manageAffiliations":978,"indexDatabases":979,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":975,"title":976},{"VOID":741},{"EN":743},[],[],[],{"volume":981,"pages":983},{"VOID":982},"51",{"VOID":984},"1-18","2015-09-01",2015,{"id":988,"createTime":989,"updateTime":990,"relativeEntities":991,"slug":992,"properties":993,"entityType":673,"verifyStatus":25,"verifyTime":990,"verifyNote":675,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1000,"fullTextUrl":26,"authors":1001,"publicationType":732,"publisherRelationship":1032,"citationCount":26,"citationInfo":26,"publishDate":1046,"publishYear":1047,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":762},"4c7e5ab1-3b75-42b6-a1e4-f0e78bc5a2d4","2023-12-11T19:04:18.521+00:00","2025-01-25T13:48:03.130+00:00",[],"Estrategias-de-diagn%C3%B3stico-prenatal-y-tratamiento-de-los-trastornos-asociados-al-embarazo-m%C3%BAltiple",{"references":994,"title":996,"doi":998},{"VOID":995},"Dommergues, 2002, Prenatal diagnosis for multiple pregnancies, Curr. Opin. Obstet. Gynecol., 14, 169, 10.1097\u002F00001703-200204000-00011\nEvans, 2001, Improvement in outcomes of multifetal pregnancy reduction with increased experience, Am. J. Obstet. Gynecol., 184, 97, 10.1067\u002Fmob.2001.108074\nLipitz, 2001, A comparative study of multifetal pregnancy reduction from triplets to twins in the first versus early second trimesters after detailed fetal screening, Ultrasound Obstet. Gynecol., 18, 35, 10.1046\u002Fj.1469-0705.2001.00431.x\nDe Catte, 2002, Obstetric outcome after fetal reduction to singleton pregnancy, Prenat. Diagn., 22, 206, 10.1002\u002Fpd.285\nDe Catte, 2002, Monochorionic high-order multiple pregnancies and multifetal pregnancy reduction, Obstet. Gynecol., 100, 561, 10.1016\u002FS0029-7844(02)02075-6\nDommergues, 1999, Multifetal pregnancy reduction and selective termination, 879\nDumez, 1991, First-trimester prenatal diagnosis in quintuplets: a practical approach using step-by-step embryo reduction, Prenat. Diagn., 11, 737, 10.1002\u002Fpd.1970110912\nMeyers, 1997, Aneuploidy in twin gestations: when is maternal age advanced?, Obstet. Gynecol., 89, 248, 10.1016\u002FS0029-7844(96)00424-3\nSpencer, 1994, Down's syndrome screening in multiple pregnancies using alpha-foetoprotein and free beta hCG, Prenat. Diagn., 18, 537, 10.1002\u002Fpd.1970140705\nWald, 1994, Maternal serum free beta-hCG levels in twin pregnancies: implications for screening for Down's syndrome, Prenat. Diagn., 14, 319, 10.1002\u002Fpd.1970140415\nSpencer, 2001, Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free beta hCG or PAPP-A levels, Prenat. Diagn., 21, 715, 10.1002\u002Fpd.152\nRaty, 2000, Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies, Prenat. Diagn., 20, 221, 10.1002\u002F(SICI)1097-0223(200003)20:3\u003C221::AID-PD787>3.0.CO;2-S\nSebire, 1996, Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation, Br. J. Obstet. Gynaecol., 103, 999, 10.1111\u002Fj.1471-0528.1996.tb09550.x\nSpencer, 2000, Screening for trisomy 21 in twin pregnancies in the first trimester using free beta-hCG and PAPP-A, combined with fetal nuchal translucency thickness, Prenat. Diagn., 20, 91, 10.1002\u002F(SICI)1097-0223(200002)20:2\u003C91::AID-PD759>3.0.CO;2-X\nYukobowich, 2001, Risk of fetal loss in twin pregnancies undergoing second trimester amniocentesis, Obstet. Gynecol., 98, 231, 10.1016\u002FS0029-7844(01)01416-8\nWapner, 1993, Prenatal diagnosis in twin gestations: a comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling, Obstet. Gynecol., 82, 49\nDe Catte, 2000, Outcome of twin gestations after first trimester chorionic villus sampling, Obstet. Gynecol., 96, 714, 10.1016\u002FS0029-7844(00)00991-1\nBrambati, 2001, Ultrasound outcome of first-trimester chorionic villus sampling for genetic investigation in multiple pregnancy, Obstet. Gynecol., 17, 209\nSepulveda, 2000, Severe polyhydramnios in twin reversed arterial perfusion sequence: successful management with intrafetal alcohol ablation of acardiac twin and amniodrainage, Ultrasound Obstet. Gynecol., 16, 260, 10.1046\u002Fj.1469-0705.2000.00212.x\nTongsong, 2002, Intrauterine treatment for an acardiac twin with alcohol injection into the umbilical artery, J. Obstet. Gynaecol. Res., 28, 76, 10.1046\u002Fj.1341-8076.2002.00017.x\nDeprest, 2000, Bipolar coagulation of the umbilical cord in complicated monochorionic twin pregnancy, Am. J. Obstet. Gynecol., 182, 340, 10.1016\u002FS0002-9378(00)70221-3\nHolmes, 2001, Monopolar thermocoagulation in acardiac twinning, Br. J. Obstet. Gynaecol., 108, 1000, 10.1016\u002FS0306-5456(01)00234-0\nTsao, 2002, Selective reduction of acardiac twin by radiofrequency ablation, Am. J. Obstet. Gynecol., 187, 635, 10.1067\u002Fmob.2002.125242\nDommergues, 1995, Twin-to-twin transfusion syndrome: selective feticide by embolization of the hydropic fetus, Fetal Diagn. Ther., 10, 26, 10.1159\u002F000264188\nDeprest, 1998, Experience with fetoscopic cord ligation, Eur. J. Obstet. Gynecol. Reprod. Biol., 81, 157, 10.1016\u002FS0301-2115(98)00181-X\nNicolini, 2001, Complicated monochorionic twin pregnancies: experience with bipolar cord coagulation, Am. J. Obstet. Gynecol., 185, 703, 10.1067\u002Fmob.2001.117190\nLopoo, 2000, Cord ultrasonic transection procedure for selective termination of a monochorionic twin, Fetal. Diagn. Ther., 15, 177, 10.1159\u002F000021001\nEvans, 1999, Selective termination for structural, chromosomal, and mendelian anomalies: international experience, Am. J. Obstet. Gynecol., 181, 893, 10.1016\u002FS0002-9378(99)70321-2\nVan Gemert, 2000, Classification of discordant fetal growth may contribute to risk stratification in monochorionic twin pregnancies, Ultrasound. Obstet. Gynecol., 16, 237, 10.1046\u002Fj.1469-0705.2000.00226.x\nQuintero, 2001, Selective photocoagulation of communicating vessels in the treatment of monochorionic twins with selective growth retardation, Am. J. Obstet. Gynecol., 185, 689, 10.1067\u002Fmob.2001.116724\nSmith, 2001, A prospective study of growth velocity in twin pregnancy, Ultrasound. Obstet. Gynecol., 18, 485, 10.1046\u002Fj.0960-7692.2001.00519.x\nSebire, 2000, Early prediction of severe twin-to-twin transfusion syndrome, Hum. Reprod., 15, 2008, 10.1093\u002Fhumrep\u002F15.9.2008\nSebire, 2001, Twin-to-twin transfusion syndrome results from dynamic asymmetrical reduction in placental anastomoses: a hypothesis, Placenta, 22, 383, 10.1053\u002Fplac.2001.0631\nBajoria, 2001, Placental regulation of insulin-like growth factor axis in monochorionic twins with chronic twin-twin transfusion syndrome, J. Clin. Endocrinol. Metab., 86, 3150, 10.1210\u002Fjc.86.7.3150\nSooranna, 2001, Discordant fetal leptin levels in monochorionic twins with chronic midtrimester twin-twin transfusion syndrome, Placenta, 22, 392, 10.1053\u002Fplac.2001.0654\nBajoria, 2000, Discordant amino acid profiles in monochorionic twins with twin-twin transfusion syndrome, Pediatr. Res., 48, 821, 10.1203\u002F00006450-200012000-00020\nBajoria, 2001, Iron metabolism in monochorionic twin pregnancies in relation to twin– twin transfusion syndrome, Hum. Reprod., 16, 567, 10.1093\u002Fhumrep\u002F16.3.567\nBajoria, 2001, Erythropoietin in monochorionic twin pregnancies in relation to twin– twin transfusion syndrome, Hum. Reprod., 16, 574, 10.1093\u002Fhumrep\u002F16.3.574\nUmur, 2001, Amniotic fluid and hemodynamic model in monochorionic twin pregnancies and twin-twin transfusion syndrome, Am. J. Physiol. Regul. Integr. Comp. Physiol., 280, R1499, 10.1152\u002Fajpregu.2001.280.5.R1499\nMahieu-Caputo, 2000, Twin-to-twin transfusion syndrome. Role of the fetal renin-angiotensin system, Am. J. Pathol., 156, 629, 10.1016\u002FS0002-9440(10)64767-0\nKilby, 2001, Renin gene expression in fetal kidneys of pregnancies complicated by twin-twin transfusion syndrome, Pediatr. Dev. Pathol., 4, 175, 10.1007\u002Fs100240010124\nMahieu-Caputo, 2001, Pathogenesis of twin-twin transfusion syndrome: the renin-angiotensin system hypothesis, Fetal. Diagn. Ther., 16, 241, 10.1159\u002F000053919\nCheung, 2000, Fetal origins of reduced arterial distensibility in the donor twin in twin-twin transfusion syndrome, Lancet, 355, 1157, 10.1016\u002FS0140-6736(00)02068-7\nVille, 1998, Endoscopic laser coagulation in the management of severe twin-to-twin transfusion syndrome, Br. J. Obstet. Gynaecol., 105, 446, 10.1111\u002Fj.1471-0528.1998.tb10132.x\nZikulnig, 1999, Prognostic factors in severe twin-twin transfusion syndrome treated by endoscopic laser surgery, Ultrasound Obstet. Gynecol., 14, 380, 10.1046\u002Fj.1469-0705.1999.14060380.x\nHecher, 2000, Endoscopic laser coagulation of placental anastomoses in 200 pregnancies with severe mid-trimester twin-to-twin transfusion syndrome, Eur. J. Obstet. Gynecol. Reprod. Biol., 92, 135, 10.1016\u002FS0301-2115(00)00437-1\nSmith, 2001, A prospective longitudinal study of growth velocity in twin pregnancy, Ultrasound Obstet. Gynecol., 18, 485, 10.1046\u002Fj.0960-7692.2001.00519.x\nMari, 2000, Long-term outcome in twin-twin transfusion syndrome treated with serial aggressive amnioreduction, Am. J. Obstet. Gynecol., 183, 211, 10.1016\u002FS0002-9378(00)66819-9\nJoa, 2001, Twin-to-twin transfusion syndrome: a review of 27 cases and the relationship between gestational age at diagnosis and serial amniocentesis on outcome, Obstet. Gynecol., 97, S46\nCincotta, 2000, Long-term outcome of twin-twin transfusion syndrome, Arch. Dis. Child., 83, F171, 10.1136\u002Ffn.83.3.F171\nTaylor, 2000, Antenatal factors at diagnosis that predict outcomes in twin-twin transfusion syndrome, Am. J. Obstet. Gynecol., 183, 1023, 10.1067\u002Fmob.2000.107368\nHaverkamp, 2001, Neurodevelopmental risks in twin-to-twin transfusion syndrome: preliminary findings, Eur. J. Paediatr. Neurol., 5, 21, 10.1053\u002Fejpn.2001.0400\nHecher, 1999, Endoscopic laser surgery vs serial amniocenteses in the treatment of severe twin-twin transfusion syndrome, Am. J. Obstet. Gynecol., 180, 717, 10.1016\u002FS0002-9378(99)70278-4\nSenat, 2002, Management of single fetal death in twin-to-twin transfusion syndrome: a role for fetal blood sampling, Ultrasound. Obstet. Gynecol., 20, 360, 10.1046\u002Fj.1469-0705.2002.00815.x\nLarroche, 1990, Brain damage in monozygous twins, Biol. Neonate, 57, 261, 10.1159\u002F000243201\nHubinont, 2000, Twin-to-twin transfusion syndrome: treatment by amniodrainage and septostomy, Eur. J. Obstet. Gynecol. Reprod. Biol., 92, 141, 10.1016\u002FS0301-2115(00)00438-3\nQuintero, 2001, Selective laser photocoagulation of communicating vessels in severe twin-twin transfusion syndrome in women with an anterior placenta, Obstet. Gynecol., 97, 477, 10.1016\u002FS0029-7844(00)01172-8\nQuintero, 2000, Selective versus non-selective laser photocoagulation of placental vessels in twin-to-twin transfusion syndrome, Ultrasound Obstet. Gynecol., 16, 230, 10.1046\u002Fj.1469-0705.2000.00265.x\nThilaganathan, 2000, Sono-endoscopic delineation of the placental vascular equator prior to selective fetoscopic laser ablation in twin-to-twin transfusion syndrome, Ultrasound Obstet. Gynecol., 16, 226, 10.1046\u002Fj.1469-0705.2000.00272.x\nLuks, 2001, Preoperative planning with magnetic resonance imaging and computerized volume rendering in twin-to-twin transfusion syndrome, Am. J. Obstet. Gynecol., 185, 216, 10.1067\u002Fmob.2001.115111\nTaylor, 2000, Identification of arterio-venous anastomoses in vivo in monochorionic twin pregnancies: preliminary report, Ultrasound Obstet. Gynecol., 16, 218, 10.1046\u002Fj.1469-0705.2000.00227.x\nMachin, 2000, Doppler sonographic demonstration of arterio-venous anastomosis in monochorionic twin gestation, Ultrasound Obstet. Gynecol., 16, 214, 10.1046\u002Fj.1469-0705.2000.00231.x\nHartung, 2000, Amniotic fluid pressure in both cavities of twin-to-twin transfusion syndrome: a vote against septostomy, Fetal Diagn. Ther., 15, 79, 10.1159\u002F000020980",{"ES":997},"Estrategias de diagnóstico prenatal y tratamiento de los trastornos asociados al embarazo múltiple",{"VOID":999},"10.1016\u002Fs1283-081x(05)43394-9","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X05433949",[1002,1017],{"id":1003,"sortIndex":36,"researcher":26,"roles":1004,"affiliations":1005,"properties":1014},"e8f517da-d7bd-42af-8398-d8ff3884fc2e",[681],[1006],{"id":26,"sortIndex":36,"affiliation":1007,"properties":26},{"id":1008,"createTime":1009,"updateTime":1009,"relativeEntities":1010,"slug":26,"properties":1011,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"2d1f2f73-1e2d-4fcd-8c9e-6438c05acf61","2023-12-26T11:16:04.126+00:00",[],{"title":1012},{"VI":1013},"Service de gynécologie–obstétrique, Groupe hospitalier Pitié-Salpêtrière, AP–HP et Université Paris VI, 47-83 boulevard de l'Hôpital, 75651 Paris cedex 13, France",{"title":1015},{"VI":1016},"M. Dommergues",{"id":1018,"sortIndex":115,"researcher":26,"roles":1019,"affiliations":1020,"properties":1029},"fddc93f9-b372-4811-b14c-4f2cbe1c9e1b",[681],[1021],{"id":26,"sortIndex":36,"affiliation":1022,"properties":26},{"id":1023,"createTime":1024,"updateTime":1024,"relativeEntities":1025,"slug":26,"properties":1026,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"60ba3490-39ae-444f-8ca3-faa24066bf18","2023-12-26T11:16:04.142+00:00",[],{"title":1027},{"VI":1028},"Service de gynécologie–obstétrique, Hôpital Antoine Béclère, AP–HP et Université Paris XI, 92000 Clamart, France",{"title":1030},{"VI":1031},"O. Picone",{"url":1000,"publisher":1033,"properties":1041},{"id":735,"createTime":736,"updateTime":736,"relativeEntities":1034,"slug":738,"properties":1035,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1038,"manageAffiliations":1039,"indexDatabases":1040,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1036,"title":1037},{"VOID":741},{"EN":743},[],[],[],{"volume":1042,"pages":1044},{"VOID":1043},"41",{"VOID":1045},"1-7","2005-01-01",2005,{"id":1049,"createTime":1050,"updateTime":1051,"relativeEntities":1052,"slug":1053,"properties":1054,"entityType":673,"verifyStatus":25,"verifyTime":1051,"verifyNote":675,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1061,"fullTextUrl":26,"authors":1062,"publicationType":732,"publisherRelationship":1092,"citationCount":26,"citationInfo":26,"publishDate":1106,"publishYear":1107,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":762},"43acb280-1c0c-4866-91c0-8788dadce0ac","2024-01-17T13:36:24.521+00:00","2024-12-29T17:06:57.149+00:00",[],"Infecciones-de-transmisi%C3%B3n-sexual",{"references":1055,"title":1057,"doi":1059},{"VOID":1056},"Newman, 2015, Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting, PLoS One, 10, 10.1371\u002Fjournal.pone.0143304\nLa Ruche, 2014, Évolution des résistances du gonocoque aux antibiotiques en France de 2001 à 2012, Bull Epidemiol Hebd, 5, 93\nBulletin des réseaux de surveillance des IST : données au 31 décembre 2013. INVS; novembre 2014.\nBulletin des réseaux de surveillance des infections sexuellement transmissibles (IST) - Rénago, Rénachla et RésIST : données au 31 décembre 2012. Saint-Maurice : InVS, 2015, consultation en ligne : http:\u002F\u002Fwww.invs.sante.fr\u002FDossiers-thematiques\u002FMaladies-infectieuses\u002FVIH-sida-IST\u002FInfections-sexuellement-transmissibles-IST\u002FBulletins-des-reseaux-de-surveillance-des-IST.\nBowen, 2015, Increase in incidence of congenital syphilis—United States, 2012-2014, MMWR Morb Mortal Wkly Rep, 64, 1241, 10.15585\u002Fmmwr.mm6444a3\nBerwald, 2009, Self-administered vaginal swabs are a feasible alternative to physician-assisted cervical swabs for sexually transmitted infection screening in the emergency department, Acad Emerg Med, 16, 360, 10.1111\u002Fj.1553-2712.2009.00359.x\nMiettinen, 1993, Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease, Am J Obstet Gynecol, 169, 1143, 10.1016\u002F0002-9378(93)90271-J\nAlthaus, 2012, Towards more robust estimates of the transmissibility of Chlamydia trachomatis, Sex Transm Dis, 39, 402, 10.1097\u002FOLQ.0b013e318248a550\nDavies, 2013, Risk of pelvic inflammatory disease after Chlamydia infection in a prospective cohort of sex workers, Sex Transm Dis, 40, 230, 10.1097\u002FOLQ.0b013e31827b9d75\nDavies, 2014, Heterogeneity in risk of pelvic inflammatory diseases after Chlamydia infection: a population-based study in Manitoba, Canada, J Infect Dis, 210, S549, 10.1093\u002Finfdis\u002Fjiu483\nHammerschlag, 1989, Chlamydial infections, J Pediatr, 114, 727, 10.1016\u002FS0022-3476(89)80128-3\nLanjouw, 2016, 2015 European guideline on the management of Chlamydia trachomatis infections, Int J STD AIDS, 27, 333, 10.1177\u002F0956462415618837\nLand, 2006, Chlamydia antibody testing in subfertile women, Drugs Today, 42, 35\nRenault, 2011, Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection, Sex Health, 8, 69, 10.1071\u002FSH10030\nChan, 2016, Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature, Infect Dis Obstet Gynecol, 2016, 5758387, 10.1155\u002F2016\u002F5758387\nTrebach, 2015, Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposures, Sex Transm Dis, 42, 233, 10.1097\u002FOLQ.0000000000000248\nTully, 1981, A newly discovered mycoplasma in the human urogenital tract, Lancet, 1, 1288, 10.1016\u002FS0140-6736(81)92461-2\nTaylor-Robinson, 2011, Mycoplasma genitalium: from chrysalis to multicolored butterfly, Clin Microbiol Rev, 24, 498, 10.1128\u002FCMR.00006-11\nHaggerty, 2011, Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease, Infect Dis Obstet Gynecol, 2006\nOliphant, 2016, Pelvic inflammatory disease associated with Chlamydia trachomatis but not Mycoplasma genitalium in New Zealand, Sex Health, 13, 43, 10.1071\u002FSH14238\nLillis, 2011, Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women, J Clin Microbiol, 49, 1990, 10.1128\u002FJCM.00129-11\nJernberg, 2008, Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study, Int J STD AIDS, 19, 676, 10.1258\u002Fijsa.2008.008038\nJensen, 2016, 2016 European guideline on Mycoplasma genitalium infections, J Eur Acad Dermatol Venereol, 30, 1650, 10.1111\u002Fjdv.13849\nKokkayil, 2015, Ureaplasma: current perspectives, Indian J Med Microbiol, 33, 205, 10.4103\u002F0255-0857.154850\nZdrodowska-Stefanow, 2006, Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases, Adv Med Sci, 51, 250\nKataoka, 2006, Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy, J Clin Microbiol, 44, 51, 10.1128\u002FJCM.44.1.51-55.2006\nSilver, 2014, Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis, Sex Transm Dis, 41, 369, 10.1097\u002FOLQ.0000000000000134\nWorld Health Organisation. Sexually transmitted infections management guidelines 1999. http:\u002F\u002Fwww.who.int\u002FHIV_AIDS.\nMark, 2008, Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults, MJ Infect Dis, 198, 1141, 10.1086\u002F591913\nTronstein, 2011, Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection, JAMA, 305, 1441, 10.1001\u002Fjama.2011.420\nBrown, 2003, Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant, JAMA, 289, 203, 10.1001\u002Fjama.289.2.203\nCorey, 2004, Once-daily valacyclovir to reduce the risk of transmission of genital herpes, N Engl J Med, 350, 11, 10.1056\u002FNEJMoa035144\nCentre national de référence des Papillomavirus humains (CNR HPV), Institut Pasteur, 2016.\nDuport, 2004, Le cancer du col de l’utérus : état des connaissances en 2014, Bull Epidemiol Hebd\nMonsonego, 2006\nAlain, 2010, Papillomavirus : les virus et la physiopathologie de l’infection, Med Ther Pediatr, 13, 5\nGavillon, 2010, How did I contract human Papillomavirus (HPV)?, Gynecol Obstet Fertil, 38, 199, 10.1016\u002Fj.gyobfe.2010.01.003\nWiner, 2006, Condom use and the risk of genital human papillomavirus infection in young women, N Engl J Med, 354, 2645, 10.1056\u002FNEJMoa053284\nHuman Papillomaviruses, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (vol. 90), 2007.\nSyrjänen, 2000\nKoutsky, 1997, Epidemiology of genital human papillomavirus infection, Am J Med, 102, 3, 10.1016\u002FS0002-9343(97)00177-0\nD'Souza, 2007, Case-control study of human papillomavirus and oropharyngeal cancer, N Engl J Med, 356, 1944, 10.1056\u002FNEJMoa065497\nFerenczy, 1995, Epidemiology and clinical pathophysiology of condylomata acuminate, Am J Obstet Gynecol, 172, 1331, 10.1016\u002F0002-9378(95)90399-2\nCox, 2006, The development of cervical cancer and its precursors: what is the role of human papillomavirus infection?, Curr Opin Obstet Gynecol, 18\nWang, 2003, Viral and host factors in human papillomavirus persistence and progression, J Natl Cancer Inst Monogr, 31, 35, 10.1093\u002Foxfordjournals.jncimonographs.a003480\nIversen, 1998, Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway, Obstet Gynecol, 91, 969\nCarter, 1993, Invasive vulvar tumors in young women- a disease of the immunosuppressed?, Gynecol Oncol, 51, 307, 10.1006\u002Fgyno.1993.1295\nANAES. Évaluation de l’intérêt de la recherche des papillomavirus humains (HPV) dans le dépistage des lésions précancéreuses et cancéreuses du col de l’utérus. Mai 2004.\nTamalet, 2016, Genotyping and follow-up of HR-HPV types detected by self-sampling in women from low socioeconomic groups not participating in regular cervical cancer screening in France, J Clin Virol, 78, 102, 10.1016\u002Fj.jcv.2016.02.027\nHaut Conseil de la Santé Publique : Avis sur les infections à HPV des jeunes filles : révision de l’âge de vaccination. Janvier 2013.\nChemlal, 2013\nJoura, 2015, A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women, N Engl J Med, 372, 711, 10.1056\u002FNEJMoa1405044\nHaute Autorité de santé. État des lieux et recommandations pour le dépistage du cancer du col de l’utérus en France. 2010.",{"ES":1058},"Infecciones de transmisión sexual",{"VOID":1060},"10.1016\u002Fs1283-081x(18)89322-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X18893225",[1063,1080],{"id":1064,"sortIndex":36,"researcher":26,"roles":1065,"affiliations":1066,"properties":1077},"b7870109-cf54-4554-9ca5-b93c5f621fa4",[681],[1067],{"id":26,"sortIndex":36,"affiliation":1068,"properties":26},{"id":1069,"createTime":1070,"updateTime":1071,"relativeEntities":1072,"slug":1073,"properties":1074,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"06538763-c522-4171-81a3-5c78cfc57486","2024-01-10T16:43:12.676+00:00","2025-06-11T19:24:55.428+00:00",[],"Institut-Fournier-25-boulevard-Saint-Jacques-75014-Paris-France",{"title":1075},{"VI":1076},"Institut Fournier, 25, boulevard Saint-Jacques, 75014 Paris, France",{"title":1078},{"VI":1079},"J.-M. Bohbot",{"id":1081,"sortIndex":115,"researcher":26,"roles":1082,"affiliations":1083,"properties":1089},"c4367592-9996-4f01-972b-815ca8971b61",[681],[1084],{"id":26,"sortIndex":36,"affiliation":1085,"properties":26},{"id":1069,"createTime":1070,"updateTime":1071,"relativeEntities":1086,"slug":1073,"properties":1087,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1088},{"VI":1076},{"title":1090},{"VI":1091},"A. Marchal",{"url":1061,"publisher":1093,"properties":1101},{"id":735,"createTime":736,"updateTime":736,"relativeEntities":1094,"slug":738,"properties":1095,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1098,"manageAffiliations":1099,"indexDatabases":1100,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1096,"title":1097},{"VOID":741},{"EN":743},[],[],[],{"volume":1102,"pages":1104},{"VOID":1103},"54",{"VOID":1105},"1-9","2018-06-01",2018,{"id":1109,"createTime":1110,"updateTime":1111,"relativeEntities":1112,"slug":1113,"properties":1114,"entityType":673,"verifyStatus":25,"verifyTime":1111,"verifyNote":675,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1121,"fullTextUrl":26,"authors":1122,"publicationType":732,"publisherRelationship":1190,"citationCount":26,"citationInfo":26,"publishDate":1203,"publishYear":755,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":762},"4e13ffda-37a5-48c4-9ae0-affd04e9d6d9","2024-01-11T02:40:00.744+00:00","2025-01-13T18:40:28.560+00:00",[],"Psiquiatr%C3%ADa-y-embarazo-la-madre-y-el-hijo",{"references":1115,"title":1117,"doi":1119},{"VOID":1116},"Cox, 1987, Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale, Br J Psychiatry, 150, 782, 10.1192\u002Fbjp.150.6.782\nBydlowski, 1997\nHoekzema, 2017, Pregnancy leads to long-lasting changes in human brain structure, Nat Neurosci, 20, 287, 10.1038\u002Fnn.4458\nSutter-Dallay, 2013\nKendell, 1987, Epidemiology of puerperal psychoses, Br J Psychiatry, 150, 662, 10.1192\u002Fbjp.150.5.662\nWinnicott, 1989\nGuedeney, 1993, Post-partum blues: a critical review of the literature, Psychiatr Enf, 36, 329\nGavin, 2005, Perinatal depression: a systematic review of prevalence and incidence, Obstet Gynecol, 106, 1071, 10.1097\u002F01.AOG.0000183597.31630.db\nBales, 2015, Prenatal psychological distress and access to mental health care in the ELFE cohort, Eur Psychiatry, 30, 322, 10.1016\u002Fj.eurpsy.2014.11.004\nBérard, 2019, The French Pregnancy Cohort: Medication use during pregnancy in the French population, PLoS One, 14, e0219095, 10.1371\u002Fjournal.pone.0219095\nMeltzer-Brody, 2011, New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum, Dialogues Clin Neurosci, 13, 89, 10.31887\u002FDCNS.2011.13.1\u002Fsmbrody\nElwood, 2019, A systematic review investigating if genetic or epigenetic markers are associated with postnatal depression, J Affect Disord, 253, 51, 10.1016\u002Fj.jad.2019.04.059\nKelly, 2001, Somatic complaints among pregnant women cared for in obstetrics: normal pregnancy or depressive and anxiety symptom amplification revisited?, Gen Hosp Psychiatry, 23, 107, 10.1016\u002FS0163-8343(01)00129-3\nSutter-Dallay, 2012, Evolution of perinatal depressive symptoms from pregnancy to two years postpartum in a low-risk sample: the MATQUID cohort, J Affect Disord, 139, 23, 10.1016\u002Fj.jad.2011.08.018\nStevens, 2019, Risk of recurrence of mood disorders during pregnancy and the impact of medication: A systematic review, J Affect Disord, 249, 96, 10.1016\u002Fj.jad.2019.02.018\nAzorin, 2012, Identifying features of bipolarity in patients with first-episode postpartum depression: findings from the international BRIDGE study, J Affect Disord, 136, 710, 10.1016\u002Fj.jad.2011.10.003\nSantos, 2017, Heterogeneity in perinatal depression: how far have we come?. A systematic review, Arch Womens Ment Health, 20, 11, 10.1007\u002Fs00737-016-0691-8\nAustin, 2007, Maternal mortality and psychiatric morbidity in the perinatal period: challenges and opportunities for prevention in the Australian setting, Med J Aust, 186, 364, 10.5694\u002Fj.1326-5377.2007.tb00940.x\nGuillard, 2017, Suicidality during perinatal period, Presse Med, 46, 565, 10.1016\u002Fj.lpm.2017.05.018\nGressier, 2017, Risk factors for suicide attempt in pregnancy and the post-partum period in women with serious mental illnesses, J Psychiatr Res, 84, 284, 10.1016\u002Fj.jpsychires.2016.10.009\nAbrams, 1995, Newborns of depressed mothers, Infant Ment Health J, 16, 233, 10.1002\u002F1097-0355(199523)16:3\u003C233::AID-IMHJ2280160309>3.0.CO;2-1\nField, 2004, Prenatal depression effects on the fetus and the newborn, Infant Behav Dev, 27, 216, 10.1016\u002Fj.infbeh.2003.09.010\nLundy, 1999, Prenatal depression effects on neonates, Infant Behav Dev, 22, 121, 10.1016\u002FS0163-6383(99)80009-5\nGressier, 2019, Negative impact of maternal antenatal depressive symptoms on neonate's behavioral characteristics, Eur Child Adolesc Psychiatry\nGentile, 2017, Untreated depression during pregnancy: Short- and long-term effects in offspring. A systematic review, Neuroscience, 342, 154, 10.1016\u002Fj.neuroscience.2015.09.001\nLeis, 2014, Associations between maternal mental health and child emotional and behavioral problems: does prenatal mental health matter?, J Abnorm Child Psychol, 42, 161, 10.1007\u002Fs10802-013-9766-4\nGaléra, 2011, Early risk factors for hyperactivity-impulsivity and inattention trajectories from age 17 months to 8 years, Arch Gen Psychiatry, 68, 1267, 10.1001\u002Farchgenpsychiatry.2011.138\nStein, 2014, Effects of perinatal mental disorders on the fetus and child, Lancet, 384, 1800, 10.1016\u002FS0140-6736(14)61277-0\nViguera, 2007, Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation, Am J Psychiatry, 164, 1817, 10.1176\u002Fappi.ajp.2007.06101639\nDi Florio, 2013, Perinatal episodes across the mood disorder spectrum, JAMA Psychiatry, 70, 168, 10.1001\u002Fjamapsychiatry.2013.279\nPope, 2014, Recognition, diagnosis and treatment of postpartum bipolar depression, Expert Rev Neurother, 14, 19, 10.1586\u002F14737175.2014.846219\nViguera, 2011, Episodes of mood disorders in 2,252 pregnancies and postpartum periods, Am J Psychiatry, 168, 1179, 10.1176\u002Fappi.ajp.2011.11010148\nSolé, 2019, Obstetric complications in bipolar disorder: The role of mental health disorders in the risk of caesarean section, J Affect Disord, 252, 458, 10.1016\u002Fj.jad.2019.04.017\nBodén, 2012, Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study, Br Med J, 345, e7085, 10.1136\u002Fbmj.e7085\nGrimm, 1966, The relationship of emotional adjustment and attitudes to the course and outcome of pregnancy, Psychosom Med, 28, 34, 10.1097\u002F00006842-196601000-00004\nUguz, 2019, Prevalence of mood and anxiety disorders during pregnancy: A case-control study with a large sample size, Psychiatry Res, 272, 316, 10.1016\u002Fj.psychres.2018.12.129\nDayan, 2014\nBundy, 2011, A systematic review and meta-analysis of the fertility of patients with schizophrenia and their unaffected relatives, Acta Psychiatr Scand, 23, 98, 10.1111\u002Fj.1600-0447.2010.01623.x\nGlangeaud-Freudenthal, 2013, Predictors of infant foster care in cases of maternal psychiatric disorders, Soc Psychiatry Psychiatr Epidemiol, 48, 553, 10.1007\u002Fs00127-012-0527-4\nGlangeaud-Freudenthal, 2014, Treatment – mother-infant inpatient units, Best Pract Res Clin Obstet Gynaecol, 28, 147, 10.1016\u002Fj.bpobgyn.2013.08.015\nWessel, 2002, Frequency of denial of pregnancy: results and epidemiological significance of a 1-year prospective study in Berlin, Acta Obstet Gynecol Scand, 81, 1021, 10.1034\u002Fj.1600-0412.2002.811105.x\n2013\nBeier, 2006, Denial of pregnancy as a reproductive dysfunction: a proposal for international classification systems, J Psychosom Res, 61, 723, 10.1016\u002Fj.jpsychores.2005.11.002\nHumeau E. Le déni de grossesse : revue de la littérature et étude de son lien potentiel avec le néonaticide. [thèse de médecine], Université de Bordeaux, 2018.\nLondon, 2017, Hyperemesis gravidarum: a review of recent literature, Pharmacology, 100, 161, 10.1159\u002F000477853\nEven, 2019, Mental health of children in foster care: a literature review, Encephale, 45, 340, 10.1016\u002Fj.encep.2019.03.006\nCleary, 2011, Methadone and perinatal outcomes: a retrospective cohort study, Am J Obstet Gynecol, 204, 139, 10.1016\u002Fj.ajog.2010.10.004\nCleary, 2013, Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women, Addiction, 108, 762, 10.1111\u002Fadd.12078\nThibaut, 2019, WFSBP and IAWMH Guidelines for the treatment of alcohol use disorders in pregnant women, World J Biol Psychiatry, 20, 17, 10.1080\u002F15622975.2018.1510185\nGlover, 2015, Prenatal stress and its effects on the fetus and the child: possible underlying biological mechanisms, Adv Neurobiol, 10, 269, 10.1007\u002F978-1-4939-1372-5_13\nBarker, 2013, Prenatal maternal depression symptoms and nutrition, and child cognitive function, Br J Psychiatry, 203, 417, 10.1192\u002Fbjp.bp.113.129486\nAllister, 2001, The effects of maternal depression on fetal heart rate response to vibroacoustic stimulation, Dev Neuropsychol, 20, 639, 10.1207\u002FS15326942DN2003_6\nField, 2001, Depressed withdrawn and intrusive mothers’ effects on their fetuses and neonates, Infant Behav Dev, 24, 27, 10.1016\u002FS0163-6383(01)00066-2\nSutter-Dallay AL, Guedeney N, Guedeney A. Psychiatrie périnatale : histoire, concepts, applications, limites, EMC (Elsevier Masson SAS, Paris), Psychiatrie, 37-200-B-20, 2010.\nMitchell, 2011, National Birth Defects Prevention Study. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008, Am J Obstet Gynecol, 205, 51, 10.1016\u002Fj.ajog.2011.02.029\nYonkers, 2009, The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists, Gen Hosp Psychiatry, 31, 403, 10.1016\u002Fj.genhosppsych.2009.04.003\nJarde, 2016, Neonatal outcomes in women with untreated antenatal depression compared with women without depression: a systematic review and meta-analysis, JAMA Psychiatry, 73, 826, 10.1001\u002Fjamapsychiatry.2016.0934\nMan, 2018, Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: A systematic review and meta-analysis, Neurosci Biobehav Rev, 86, 1, 10.1016\u002Fj.neubiorev.2017.12.007\nMezzacappa, 2017, Risk for autism spectrum disorders according to period of prenatal antidepressant exposure: a systematic review and meta-analysis, JAMA Pediatr, 171, 555, 10.1001\u002Fjamapediatrics.2017.0124\nWard, 2018, Recommendations for the use of ECT in pregnancy: literature review and proposed clinical protocol, Arch Womens Ment Health, 21, 715, 10.1007\u002Fs00737-018-0851-0\nNational Institute for Health and Care Excellence, 2014. Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance. https:\u002F\u002Fwww.nice.org.uk\u002Fguidance\u002Fcg45.\nSutter-Dallay, 2014, Le lithium et la grossesse, Ann Med Psychol, 172, 229\nMunk-Olsen, 2018, Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies, Lancet Psychiatry, 5, 644, 10.1016\u002FS2215-0366(18)30180-9\nDiav-Citrin, 2014, Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study, Am J Psychiatry, 171, 785, 10.1176\u002Fappi.ajp.2014.12111402\nEpstein, 2014, Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges, Drug Health Patient Saf, 7, 7, 10.2147\u002FDHPS.S50556\nForsberg, 2018, Maternal mood disorders and lithium exposure in utero were not associated with poor cognitive development during childhood, Acta Paediatr, 107, 1379, 10.1111\u002Fapa.14152\nSchou, 1973, Lithium and pregnancy. 3. Lithium ingestion by children breast-fed by women on lithium treatment, Br Med J, 2, 138, 10.1136\u002Fbmj.2.5859.138\nVan der Lugt, 2012, Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies, Early Hum Dev, 88, 375, 10.1016\u002Fj.earlhumdev.2011.09.013\nCasassus, 2017, France bans sodium-alproate use in case of pregnancy, Lancet, 390, 217, 10.1016\u002FS0140-6736(17)31866-4\nHernández-Díaz, 2012, Comparative safety of antiepileptic drugs during pregnancy, Neurology, 78, 1692, 10.1212\u002FWNL.0b013e3182574f39\nHaskey, 2017, Mood stabilizers in pregnancy and child developmental outcomes: A systematic review, Aust N Z J Psychiatry, 51, 1087, 10.1177\u002F0004867417726175\nBaker, 2015, IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study, Neurology, 84, 382, 10.1212\u002FWNL.0000000000001182\nMahli, 2005, Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders, Aust N Z J Psychiatry, 49, 1087\nKong, 2018, The risks associated with the use of lamotrigine during pregnancy, Int J Psychiatry Clin Pract, 22, 2, 10.1080\u002F13651501.2017.1341986\nDiav-Citrin, 2005, Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study, J Clin Psychiatry, 66, 317, 10.4088\u002FJCP.v66n0307\nMcAllister-Williams, 2017, British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017, J Psychopharmacol, 31, 519, 10.1177\u002F0269881117699361\nMcKenna, 2005, Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study, J Clin Psychiatry, 66, 444, 10.4088\u002FJCP.v66n0406\nNewham, 2008, Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study, Br J Psychiatry, 192, 333, 10.1192\u002Fbjp.bp.107.041541\nDamkier, 2018, The safety of second-generation antipsychotics during pregnancy: a clinically focused review, CNS Drugs, 32, 351, 10.1007\u002Fs40263-018-0517-5\nPoels, 2018, Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis, Eur Child Adolesc Psychiatry, 27, 1209, 10.1007\u002Fs00787-018-1177-1\nSheehy, 2019, Association between incident exposure to benzodiazepines in early pregnancy and risk of spontaneous abortion, JAMA Psychiatry, 10.1001\u002Fjamapsychiatry.2019.0963\nShyken, 2019, Benzodiazepines in pregnancy, Clin Obstet Gynecol, 62, 156, 10.1097\u002FGRF.0000000000000417\nBoyars, 2018, Treatment of perinatal opioid use disorder, Obstet Gynecol Clin North Am, 45, 511, 10.1016\u002Fj.ogc.2018.05.001\nMolyneaux, 2018, Antidepressants for preventing postnatal depression, Cochrane Database Syst Rev, CD004363\nO’Connor, 2019\nGraham, 2018, Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period?, J Affect Disord, 228, 216, 10.1016\u002Fj.jad.2017.12.022\nHeron, 2005, Postnatal euphoria: are “the highs” an indicator of bipolarity?, Bipolar Disord, 7, 103, 10.1111\u002Fj.1399-5618.2005.00185.x\nSharma, 2010, Screening for bipolar disorder during pregnancy and the postpartum period, J Obstet Gynaecol Can, 32, 278, 10.1016\u002FS1701-2163(16)34456-5\nSharma, 2017, Bipolar postpartum depression: An update and recommendations, J Affect Disord, 219, 105, 10.1016\u002Fj.jad.2017.05.014\nO’Hara, 2014, Perinatal mental illness: definition, description and aetiology, Best Pract Res Clin Obstet Gynaecol, 28, 3, 10.1016\u002Fj.bpobgyn.2013.09.002\nHoward, 2014, Non-psychotic mental disorders in the perinatal period, Lancet, 384, 1775, 10.1016\u002FS0140-6736(14)61276-9\nSharma, 2018, Should all women with postpartum depression be screened for bipolar disorder?, Med Hypotheses, 118, 26, 10.1016\u002Fj.mehy.2018.06.016\nSharma, 2014, A prospective study of diagnostic conversion of major depressive disorder to bipolar disorder in pregnancy and postpartum, Bipolar Disord, 16, 16, 10.1111\u002Fbdi.12140\nMunk-Olsen, 2012, Psychiatric disorders with postpartum onset: possible early manifestations of bipolar affective disorders, Arch Gen Psychiatry, 69, 428, 10.1001\u002Farchgenpsychiatry.2011.157\nKhan, 2015, Post-partum depressive episodes and bipolar disorder, Lancet, 385, 771, 10.1016\u002FS0140-6736(15)60433-0\nGressier, 2015, Post-partum psychosis, Rev Prat, 65, 232\nOlde, 2006, Posttraumatic stress following childbirth: a review, Clin Psychol Rev, 26, 1, 10.1016\u002Fj.cpr.2005.07.002\nAyers, 2016, The aetiology of post-traumatic stress following childbirth: a meta-analysis and theoretical framework, Psychol Med, 46, 1121, 10.1017\u002FS0033291715002706\nCohn, 1990, Face-to-face interactions of postpartum depressed and nondepressed mother-infant pairs at 2 months, Dev Psychol, 26, 15, 10.1037\u002F0012-1649.26.1.15\nMurray, 1996, The role of infant factors in postnatal depression and mother-infant interactions, Dev Med Child Neurol, 38, 109, 10.1111\u002Fj.1469-8749.1996.tb12082.x\nTaka-Eilola Nèe Riekki, 2019, Severe mood disorders and schizophrenia in the adult offspring of antenatally depressed mothers in the Northern Finland 1966 Birth Cohort: Relationship to parental severe mental, disorder, J. Affect Disord, 249, 63, 10.1016\u002Fj.jad.2019.02.011\nJunge, 2017, The impact of perinatal depression on children's social-emotional development: a longitudinal study, Matern Child Health J, 21, 607, 10.1007\u002Fs10995-016-2146-2\nRamsauer, 2018, Mothers with acute and chronic postpartum psychoses and impact on the mother-infant interaction, Schizophr Res, 197, 45, 10.1016\u002Fj.schres.2018.02.032\nWendland, 2017, Impact des troubles maternels borderline et psychotiques sur les relations mère-enfant : une revue de la littérature. Carnet de notes sur les maltraitances, Infant, 6, 5\nApter, 2017, The still-face: a greater challenge for infants of mothers with borderline personality disorder, J Pers Disord, 31, 156, 10.1521\u002Fpedi_2016_30_243\nNewman, 2007, Borderline personality disorder, mother-infant interaction and parenting perceptions: preliminary findings, Z J Psychiatry, 41, 598\nSethna, 2015, Paternal depression in the postnatal period and early father-infant interactions, Parent Sci Pract, 15, 1, 10.1080\u002F15295192.2015.992732\nGressier, 2015, Dépression paternelle du post-partum : revue de la littérature, Presse Med, 44, 418, 10.1016\u002Fj.lpm.2014.09.022",{"ES":1118},"Psiquiatría y embarazo: la madre y el hijo",{"VOID":1120},"10.1016\u002Fs1283-081x(20)44317-6","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20443176",[1123,1148,1160,1175],{"id":1124,"sortIndex":36,"researcher":26,"roles":1125,"affiliations":1126,"properties":1145},"e8dfbf78-5d2f-4c42-b9a6-c6181aa22a9e",[681],[1127,1137],{"id":1128,"sortIndex":115,"affiliation":1129,"properties":1136},"6a7eead7-fe23-47ec-8748-427916fd3278",{"id":1130,"createTime":1131,"updateTime":1131,"relativeEntities":1132,"slug":26,"properties":1133,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7026e54f-25e2-4873-80fb-b3cc2b2dd806","2024-01-11T02:40:00.770+00:00",[],{"title":1134},{"VI":1135},"Réseau de psychiatrie périnatale, Pôle universitaire de psychiatrie adulte (UNIVA), CH Charles-Perrens, Bordeaux, France",{},{"id":26,"sortIndex":36,"affiliation":1138,"properties":26},{"id":1139,"createTime":1140,"updateTime":1140,"relativeEntities":1141,"slug":26,"properties":1142,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"206a4422-3db1-4d8d-9c45-59e1040658b4","2024-01-11T02:40:00.758+00:00",[],{"title":1143},{"VI":1144},"Inserm 1219, Bordeaux Population Health Center, Université de Bordeaux, Bordeaux, France",{"title":1146},{"VI":1147},"A.-L. Sutter-Dallay",{"id":1149,"sortIndex":115,"researcher":26,"roles":1150,"affiliations":1151,"properties":1157},"cedb144f-727c-4a79-8678-8995dbb08498",[681],[1152],{"id":26,"sortIndex":36,"affiliation":1153,"properties":26},{"id":1130,"createTime":1131,"updateTime":1131,"relativeEntities":1154,"slug":26,"properties":1155,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1156},{"VI":1135},{"title":1158},{"VI":1159},"G. Scotta",{"id":1161,"sortIndex":59,"researcher":26,"roles":1162,"affiliations":1163,"properties":1172},"cb38a56a-0cf2-4baf-9438-f66c74c1f0a7",[681],[1164],{"id":26,"sortIndex":36,"affiliation":1165,"properties":26},{"id":1166,"createTime":1167,"updateTime":1167,"relativeEntities":1168,"slug":26,"properties":1169,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"73821e33-22b2-4157-9494-f19615304845","2024-01-11T02:40:00.786+00:00",[],{"title":1170},{"VI":1171},"Centre de recherche en épidémiologie et santé des populations, Université de Versailles-Saint-Quentin-en-Yvelines, Inserm U1178, Université Paris-Sud, Service de psychiatrie, Hôpital de Bicêtre, Hôpitaux universitaires Paris-Sud, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France",{"title":1173},{"VI":1174},"F. Gressier",{"id":1176,"sortIndex":114,"researcher":26,"roles":1177,"affiliations":1178,"properties":1187},"3ed8f548-a798-4163-987b-828d9acc7b56",[681],[1179],{"id":26,"sortIndex":36,"affiliation":1180,"properties":26},{"id":1181,"createTime":1182,"updateTime":1182,"relativeEntities":1183,"slug":26,"properties":1184,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b1e9b97c-1f11-48ce-a2c8-6da78dcd3516","2024-01-11T02:40:00.777+00:00",[],{"title":1185},{"VI":1186},"Pôle universitaire de psychiatrie de l’enfant et de l’adolescent, CH Charles-Perrens, 121, rue de la Béchade, 33000 Bordeaux, France",{"title":1188},{"VI":1189},"S. Lemoigne",{"url":1121,"publisher":1191,"properties":1199},{"id":735,"createTime":736,"updateTime":736,"relativeEntities":1192,"slug":738,"properties":1193,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1196,"manageAffiliations":1197,"indexDatabases":1198,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1194,"title":1195},{"VOID":741},{"EN":743},[],[],[],{"volume":1200,"pages":1201},{"VOID":749},{"VOID":1202},"1-13","2020-10-01",{"id":1205,"createTime":1206,"updateTime":1207,"relativeEntities":1208,"slug":1209,"properties":1210,"entityType":673,"verifyStatus":25,"verifyTime":1217,"verifyNote":675,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1218,"fullTextUrl":26,"authors":1219,"publicationType":732,"publisherRelationship":1262,"citationCount":26,"citationInfo":26,"publishDate":1275,"publishYear":1276,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":762},"a3fa7cab-efc4-4cc1-8a30-32af3cb09b70","2024-01-29T05:46:36.823+00:00","2024-12-17T05:43:02.879+00:00",[],"Histerectom%C3%ADa-por-v%C3%ADa-abdominal-por-lesiones-benignas",{"references":1211,"title":1213,"doi":1215},{"VOID":1212},"Carlson, 1993, Indications for hysterectomy, N. Engl. J. Med., 328, 856, 10.1056\u002FNEJM199303253281207\nCosson, 1997\nSubtil, 1997, Épidémiologie des hystérectomies, 151\nMcPherson, 2004, Severe complications of hysterectomy: the VALUE study, BJOG, 111, 688, 10.1111\u002Fj.1471-0528.2004.00174.x\nVillet, 1986, 164\nFlory, 2006, The psychosocial outcomes of total and subtotal hysterectomy: a randomized controlled trial, J. Sex. Med., 3, 483, 10.1111\u002Fj.1743-6109.2006.00229.x\nJohnson, 2005, Methods of hysterectomy: systematic review and meta-analysis of randomised controlled trials, BMJ, 330, 1478, 10.1136\u002Fbmj.330.7506.1478\nDavid-Montefiore, 2007, Surgical routes and complications of hysterectomy for benign disorders: a prospective observational study in French university hospitals, Hum. Reprod., 22, 260, 10.1093\u002Fhumrep\u002Fdel336\nPerineau, 1992, Complications of hysterectomies, Rev. Fr. Gynecol. Obstet., 87, 120\nMiskry, 2003, Randomized, prospective, double-blind comparison of abdominal and vaginal hysterectomy in women without uterovaginal prolapse, Acta Obstet. Gynecol. Scand., 82, 351, 10.1034\u002Fj.1600-0412.2003.00115.x\nCosson, 2001, Long-term complications of vaginal hysterectomy: a case control study, Eur. J. Obstet. Gynecol. Reprod. Biol., 94, 239, 10.1016\u002FS0301-2115(00)00339-0\nDebodinance, 2000, Comparison of the Bologna and Ingelman-Sundberg procedures for stress incontinence associated with genital prolapse: ten-year follow-up of a prospective randomized study, J. Gynecol. Obstet. Biol. Reprod. (Paris), 29, 148\nKovac, 2000, Hysterectomy outcomes in patients with similar indications, Obstet. Gynecol., 95, 787\nMarana, 1999, Laparoscopically assisted vaginal hysterectomy versus total abdominal hysterectomy: a prospective, randomized, multicenter study, Am. J. Obstet. Gynecol., 180, 270, 10.1016\u002FS0002-9378(99)70199-7\nBenassi, 2002, Abdominal or vaginal hysterectomy for enlarged uteri: a randomized clinical trial, Am. J. Obstet. Gynecol., 187, 1561, 10.1067\u002Fmob.2002.127596\nLanger, 1989, The effect of total abdominal hysterectomy on bladder function in asymptomatic women, Obstet. Gynecol., 74, 205\nVervest, 1989, Non-radical hysterectomy and the function of the lower urinary tract. II: Urodynamic quantification of changes in evacuation function, Acta Obstet. Gynecol. Scand., 68, 231, 10.3109\u002F00016348909020994\nSmith, 1990, Disordered colorectal motility in intractable constipation following hysterectomy, Br. J. Surg., 77, 1361, 10.1002\u002Fbjs.1800771214\nHeaton, 1993, Bowel function and irritable bowel symptoms after hysterectomy and cholecystectomy--a population based study, Gut, 34, 1108, 10.1136\u002Fgut.34.8.1108\nTaylor, 1990, Effects of hysterectomy on bowel and bladder function, Int. J. Colorectal Dis., 5, 228, 10.1007\u002FBF00303282\nLonnee-Hoffmann, 2006, Sexual experience of partners after hysterectomy, comparing subtotal with total abdominal hysterectomy, Acta Obstet. Gynecol. Scand., 85, 1389, 10.1080\u002F00016340600917316\nMokate, 2006, Hysterectomy and sexual function, J. Br. Menopause Soc., 12, 153, 10.1258\u002F136218006779160607\nMonroy-Lozano, 2006, Dyspareunia after total abdominal hysterectomy. Anatomical relation, Cir. Cir., 74, 257\nSchofield, 1991, Self-reported long-term outcomes of hysterectomy, Br. J. Obstet. Gynaecol., 98, 1129, 10.1111\u002Fj.1471-0528.1991.tb15365.x\nKuppermann, 2004, Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial, JAMA, 291, 1447, 10.1001\u002Fjama.291.12.1447",{"ES":1214},"Histerectomía por vía abdominal por lesiones benignas",{"VOID":1216},"10.1016\u002Fs1283-081x(09)70786-6","2024-12-17T05:43:02.878+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X09707866",[1220,1235,1250],{"id":1221,"sortIndex":36,"researcher":26,"roles":1222,"affiliations":1223,"properties":1232},"883b42b1-48b2-4f70-bff0-022de4a8a437",[681],[1224],{"id":26,"sortIndex":36,"affiliation":1225,"properties":26},{"id":1226,"createTime":1227,"updateTime":1227,"relativeEntities":1228,"slug":26,"properties":1229,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"3b241b0d-9ca2-403d-8622-f33e645340b5","2024-01-29T05:46:36.836+00:00",[],{"title":1230},{"VI":1231},"Service de chirurgie gynécologique, Hôpital Jeanne de Flandre, 2, avenue Oscar-Lambret, 59 000 Lille, France",{"title":1233},{"VI":1234},"F. Sabban",{"id":1236,"sortIndex":114,"researcher":26,"roles":1237,"affiliations":1238,"properties":1247},"3a102a15-d618-472e-b129-ba3e0af4cd2a",[681],[1239],{"id":26,"sortIndex":36,"affiliation":1240,"properties":26},{"id":1241,"createTime":1242,"updateTime":1242,"relativeEntities":1243,"slug":26,"properties":1244,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"12e5431b-0d79-48b2-9981-a345b7543c6a","2024-01-29T05:46:36.861+00:00",[],{"title":1245},{"VI":1246},"Professeur au Collège de médecine, chef du service de chirurgie générale et gynécologique, Hôpital des Diaconesses, 18, rue du Sergent-Beauchat, 75012 Paris, France",{"title":1248},{"VI":1249},"R. Villet",{"id":1251,"sortIndex":115,"researcher":26,"roles":1252,"affiliations":1253,"properties":1259},"296a2e1f-9863-4b85-a685-b9e3c2aa7506",[681],[1254],{"id":26,"sortIndex":36,"affiliation":1255,"properties":26},{"id":1226,"createTime":1227,"updateTime":1227,"relativeEntities":1256,"slug":26,"properties":1257,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1258},{"VI":1231},{"title":1260},{"VI":1261},"P. Collinet",{"url":1218,"publisher":1263,"properties":1271},{"id":735,"createTime":736,"updateTime":736,"relativeEntities":1264,"slug":738,"properties":1265,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1268,"manageAffiliations":1269,"indexDatabases":1270,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1266,"title":1267},{"VOID":741},{"EN":743},[],[],[],{"volume":1272,"pages":1274},{"VOID":1273},"45",{"VOID":1105},"2009-01-01",2009,{"id":1278,"createTime":1279,"updateTime":1280,"relativeEntities":1281,"slug":1282,"properties":1283,"entityType":673,"verifyStatus":25,"verifyTime":1280,"verifyNote":675,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1290,"fullTextUrl":26,"authors":1291,"publicationType":732,"publisherRelationship":1431,"citationCount":26,"citationInfo":26,"publishDate":1443,"publishYear":986,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":762},"33a8fdbd-4ffe-4f7a-8a60-f9473cafeea8","2024-01-15T09:16:21.935+00:00","2024-12-17T10:55:30.380+00:00",[],"Control-del-embarazo-normal",{"references":1284,"title":1286,"doi":1288},{"VOID":1285},"Vendittelli, 2001, Suivi clinique et paraclinique d’une grossesse normale, J Gynecol Obstet Biol Reprod, 30, 51\nThoulon JM, Fleurette F, Collège national des gynécologues et obstétriciens français. Paris: Société française de médecine périnatale, Fédération nationale des associations de sages-femmes. Paris: Mèdecine Périnatale. Guide de surveillance de la grossesse. Paris: ANDEM; 1996. 176 p.\nVilain, 2005\nBlondel B, Kermarrec M, Direction de la recherche dleedSP, Paris. DGdlSDGS, Paris. INdlSedlRMINSERM. Enquete nationale périnatale 2010 : les naissances en 2010 et leur évolution depuis 2003. 2011. 118 p.\nPauchet-Traversat AF, Dosquet P, Haute Autorité de santé. Saint-Denis: Syndicat national des gynécologues et obstétriciens de France. Comment mieux informer les femmes enceintes ? Recommandations pour les professionnels de santé. Paris: HAS, 2005.\nNordmann R, Académie nationale de médecine. Paris: Consommation d’alcool, de tabac ou de cannabis au cours de la grossesse, 2004.\nAlliance contre le tabac. Paris, information. Appr, Ligue nationale contre le cancer. Paris, Réseau européen hôpital sans tabac, Réseau hôpital sans tabac. Paris. Grossesse et tabac. Conférence de consensus. 2005. 480 p.\nAubel, 2009, Faculté de médecine Joseph-Fourier. Université de Grenoble 1. La Tronche FRA. Voyage et grossesse. Place des professionnels de santé dans le conseil aux femmes enceintes, Rev Prat, 59, 23\nAyoubi JM, Hirt R, Badiou W, Hininger-Favier I, Favier M, Zraik-Ayoubi F, et al. Nutrition et femme enceinte. EMC Gynécologie\u002FObstétrique 2012 [Article 5-042-A-10].\nGoulet, 2008, La listériose de la femme enceinte et du nouveau-né en France : évolution de 1984 à 2006, Bull Epidemiol Hebd, 107\nHaute Autorité de santé. Saint-Denis: Toxoplasmose et rubéole au cours de la grossesse : quelles recommandations pour la prévention et le dépistage ? Focus. HAS Actual Prat 2010;(20):1.\nLacroix, 2009, Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database, Eur J Clin Pharmacol, 65, 839, 10.1007\u002Fs00228-009-0647-2\nHaddad, 2002, Herpès génital et grossesse, Gynecol Obstet Fertil, 23\nMignon, 1996, Agence nationale pour le développement de l’évaluation médicale. Recommandations et références médicales. Gynécologie - obstétrique : la surveillance biologique de la femme enceinte en bonne santé et sans antécédents pathologiques, Concours Med, 118, 3\nMoty-Monnereau, 2005, Dépistage prénatal des cytomégalovirus en France : une augmentation des pratiques de prescription de 2000 à 2003, Rev Epidemiol Sante Publique, 53, 591, 10.1016\u002FS0398-7620(05)84739-X\nAudibert, 2002, Pour ou contre le dépistage systématique du CMV chez la femme enceinte, Gynecol Obstet Fertil, 30, 994, 10.1016\u002FS1297-9589(02)00494-0\nHaute Autorité de santé, 2007, Évaluation des stratégies de dépistage de la trisomie 21: recommandation en santé publique de la Haute Autorité de santé (juin 2007), Gynecol Obstet Fertil, 35, 1071\nLetourneau, 2013, Mise en place du dépistage de la trisomie 21 au premier trimestre dans un réseau périnatal de santé : exemple du réseau Périnat 92-Sud, J Gynecol Obstet Biol Reprod, 42, 647, 10.1016\u002Fj.jgyn.2012.07.008\nBerkane, 2004, Supplémentation de la femme enceinte, J Gynecol Obstet Biol Reprod, 33, S33, 10.1016\u002FS0368-2315(04)96662-8\nDehe, 2000, Prévention primaire des anomalies de fermeture du tube neural par supplémentation périconceptionnelle en acide folique, Bull Epidemiol Hebd, 87\nBenachi, 2013, Vitamine D et grossesse, Presse Med, 42, 1377, 10.1016\u002Fj.lpm.2013.07.007\nLuton, 2011, Iodine deficiency in northern Paris area: impact on fetal thyroid mensuration, Plos One, 6, e14707, 10.1371\u002Fjournal.pone.0014707\nLemery, 2010, Dossier grossesse à risque, Concours Med, 132, 318\nDucarme, 2007, Pathologies thyroidiennes et grossesse, Rev Med Interne, 28, 314, 10.1016\u002Fj.revmed.2007.01.011\nBura-Rivière, 2012, Thrombophilie et grossesse : maladies chroniques et grossesse, Rev Prat, 62, 937\nGaltier, 2003, Poids et grossesse : avant, pendant, après, Cah Nutr Diet, 38, 287\nDeruelle, 2012, Diabète et obésité : un défi obstétrical !, Med Mal Metab, 6, 294\nCrequat, 2000, Biométrie 2000. Tables de croissance fœtale par le Collège français d’échographie fœtale (CFEF) et l’Inserm U 155, Gynecol Obstet Fertil, 28, 435\nGodeau, 2004\nBismuth, 2012, Management of pregnancy in women with type 1 diabetes mellitus: guidelines of the French-Speaking Diabetes Society (Societe francophone du diabete [SFD]), Diabetes Metab, 38, 205, 10.1016\u002Fj.diabet.2012.02.010\nSureau C, Henrion R. Rapport du Comité national technique de l’échographie de dépistage prénatal. Paris: Ministère des solidarités, de la santé et de la famille; 2005. 71 p.\nMorel, 2002, Violences conjugales et grossesse, Dossiers Obstet, 18\nLarsen, 2008, Group B Streptococcus and pregnancy: a review, Am J Obstet Gynecol, 198, 440, 10.1016\u002Fj.ajog.2007.11.030\nHaute Autorité de santé. Allaitement maternel. Mise en œuvre et poursuite dans les 6 premiers mois de vie de l’enfant. www.has-sante.fr\u002Fportail\u002Fjcms\u002Fc_240729\u002Ffr\u002Fallaitement-maternel-mise-en-oeuvre-et-poursuite-dans-les-six-premiers-mois-de-vie-de-lenfant.\nAbramowitz, 2003, Complications anales de la grossesse et de l’accouchement, Gastroenterol Clin Biol, 27, 277",{"ES":1287},"Control del embarazo normal",{"VOID":1289},"10.1016\u002Fs1283-081x(15)74762-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X15747624",[1292,1317,1336,1355,1374,1393,1412],{"id":1293,"sortIndex":111,"researcher":26,"roles":1294,"affiliations":1295,"properties":1314},"b4810321-7b7a-489e-9508-244096ac266d",[681],[1296,1304],{"id":26,"sortIndex":36,"affiliation":1297,"properties":26},{"id":1298,"createTime":1299,"updateTime":1299,"relativeEntities":1300,"slug":26,"properties":1301,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"c42ac066-0c3f-4177-991a-4c06da578017","2024-01-15T09:16:22.263+00:00",[],{"title":1302},{"VI":1303},"Département de gynécologie–obstétrique, Hôpital Beaujon, 100, boulevard du Général-Leclerc, 92110 Clichy, France",{"id":1305,"sortIndex":115,"affiliation":1306,"properties":1313},"0c4b2cdd-302e-4ecd-a3ea-db4b2c141d3c",{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1309,"slug":26,"properties":1310,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"45931dc6-b51e-4d98-956b-4acbdca7b99a","2024-01-15T09:16:22.299+00:00",[],{"title":1311},{"VI":1312},"Université Paris-VII, 5, rue Thomas-Mann, 75013 Paris, France",{},{"title":1315},{"VI":1316},"E. Pernin",{"id":1318,"sortIndex":59,"researcher":26,"roles":1319,"affiliations":1320,"properties":1333},"49fcd4a4-a052-45fe-a475-a61e46a8eeb5",[681],[1321,1326],{"id":26,"sortIndex":36,"affiliation":1322,"properties":26},{"id":1298,"createTime":1299,"updateTime":1299,"relativeEntities":1323,"slug":26,"properties":1324,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1325},{"VI":1303},{"id":1327,"sortIndex":115,"affiliation":1328,"properties":1332},"5db52ee1-da8a-4be8-b624-b0d6f0015613",{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1329,"slug":26,"properties":1330,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1331},{"VI":1312},{},{"title":1334},{"VI":1335},"P. Chatel",{"id":1337,"sortIndex":114,"researcher":26,"roles":1338,"affiliations":1339,"properties":1352},"9b595b01-c1bf-4f6f-a6f4-5e6fed33320d",[681],[1340,1345],{"id":26,"sortIndex":36,"affiliation":1341,"properties":26},{"id":1298,"createTime":1299,"updateTime":1299,"relativeEntities":1342,"slug":26,"properties":1343,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1344},{"VI":1303},{"id":1346,"sortIndex":115,"affiliation":1347,"properties":1351},"425ff492-c501-4e8c-ad64-31ae94ab46f6",{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1348,"slug":26,"properties":1349,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1350},{"VI":1312},{},{"title":1353},{"VI":1354},"O. Poujade",{"id":1356,"sortIndex":115,"researcher":26,"roles":1357,"affiliations":1358,"properties":1371},"cd8489b1-66c4-46c5-84c1-41d0a2cca8eb",[681],[1359,1364],{"id":26,"sortIndex":36,"affiliation":1360,"properties":26},{"id":1298,"createTime":1299,"updateTime":1299,"relativeEntities":1361,"slug":26,"properties":1362,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1363},{"VI":1303},{"id":1365,"sortIndex":115,"affiliation":1366,"properties":1370},"905d3dcf-2605-4ad2-b5aa-733aa31f45fb",{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1367,"slug":26,"properties":1368,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1369},{"VI":1312},{},{"title":1372},{"VI":1373},"C. Duvillier",{"id":1375,"sortIndex":36,"researcher":26,"roles":1376,"affiliations":1377,"properties":1390},"7f19255c-9eeb-4371-ac7a-d21c93d69f8c",[681],[1378,1383],{"id":26,"sortIndex":36,"affiliation":1379,"properties":26},{"id":1298,"createTime":1299,"updateTime":1299,"relativeEntities":1380,"slug":26,"properties":1381,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1382},{"VI":1303},{"id":1384,"sortIndex":115,"affiliation":1385,"properties":1389},"ee5ff331-6ba9-4c8f-a10e-1cd9ff4fedda",{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1386,"slug":26,"properties":1387,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1388},{"VI":1312},{},{"title":1391},{"VI":1392},"P.-F. Ceccaldi",{"id":1394,"sortIndex":135,"researcher":26,"roles":1395,"affiliations":1396,"properties":1409},"598cd99b-b23d-4cb4-a0a2-77cd4ac53a34",[681],[1397,1402],{"id":26,"sortIndex":36,"affiliation":1398,"properties":26},{"id":1298,"createTime":1299,"updateTime":1299,"relativeEntities":1399,"slug":26,"properties":1400,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1401},{"VI":1303},{"id":1403,"sortIndex":115,"affiliation":1404,"properties":1408},"9f46ef93-69b2-4bb4-9345-22328d9ee668",{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1405,"slug":26,"properties":1406,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1407},{"VI":1312},{},{"title":1410},{"VI":1411},"D. Luton",{"id":1413,"sortIndex":162,"researcher":26,"roles":1414,"affiliations":1415,"properties":1428},"01ee54a2-6d65-4bff-a9b5-892e713def25",[681],[1416,1421],{"id":26,"sortIndex":36,"affiliation":1417,"properties":26},{"id":1298,"createTime":1299,"updateTime":1299,"relativeEntities":1418,"slug":26,"properties":1419,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1420},{"VI":1303},{"id":1422,"sortIndex":115,"affiliation":1423,"properties":1427},"cdc371a5-98b4-4112-afb6-71edda0185c8",{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1424,"slug":26,"properties":1425,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1426},{"VI":1312},{},{"title":1429},{"VI":1430},"C. Davitian",{"url":1290,"publisher":1432,"properties":1440},{"id":735,"createTime":736,"updateTime":736,"relativeEntities":1433,"slug":738,"properties":1434,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1437,"manageAffiliations":1438,"indexDatabases":1439,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1435,"title":1436},{"VOID":741},{"EN":743},[],[],[],{"volume":1441,"pages":1442},{"VOID":982},{"VOID":915},"2015-12-01",{"id":1445,"createTime":1446,"updateTime":1447,"relativeEntities":1448,"slug":1449,"properties":1450,"entityType":673,"verifyStatus":25,"verifyTime":1447,"verifyNote":675,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1457,"fullTextUrl":26,"authors":1458,"publicationType":732,"publisherRelationship":1524,"citationCount":26,"citationInfo":26,"publishDate":1538,"publishYear":1539,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":762},"12760f9e-4506-4961-a309-733af58911ac","2023-12-23T06:11:29.605+00:00","2025-01-27T12:33:59.445+00:00",[],"Contribuci%C3%B3n-de-la-tomograf%C3%ADa-por-emisi%C3%B3n-de-positrones-con-fluorodesoxiglucosa-18F-en-las-pacientes-afectadas-de-c%C3%A1ncer-genital-o-mamario",{"references":1451,"title":1453,"doi":1455},{"VOID":1452},"Bourguet, 2003, Utilisation de la tomographie par émission de positons au [18F]-FDG en cancérologie, Bull. Cancer, 90\nFischman, 1993, FDG-PET in oncology: there's more to it than looking at picture, J. Nucl. Med., 34, 6\nEnomoto, 1991, Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma, Kaku Igaku, 28, 1353\nAntoch, 2004, Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET\u002FCT) for tumor staging in solid tumors: comparison with CT and PET, J. Clin. Oncol., 22, 4357, 10.1200\u002FJCO.2004.08.120\nWarburg, 1924, The metabolism of cancer cells, Biochem. Zschr., 152, 129\nHaberkorn, 1994, FDG uptake, tumor proliferation and expression of glucolysis associated genes in animal models, Nucl. Med. Biol., 21, 827, 10.1016\u002F0969-8051(94)90162-7\nGolshani-Hebroni, 1997, Hexokinase binding to mitochondria: a basis for proliferative energy metabolism, J. Bioenerg. Biomembr., 29, 331, 10.1023\u002FA:1022442629543\nYounes, 1997, Overexpression of Glut1 and Glut3 in stage non-small cell lung carcinoma is associated with poor survival, Cancer, 80, 1046, 10.1002\u002F(SICI)1097-0142(19970915)80:6\u003C1046::AID-CNCR6>3.0.CO;2-7\nFlier, 1987, Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogens, Science, 235, 1492, 10.1126\u002Fscience.3103217\nMochizuki, 2001, FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models, J. Nucl. Med., 42, 1551\nVranjesevic, 2003, Relationship between 18F-FDG uptake and breast density in women with normal breast tissue, J. Nucl. Med., 44, 1238\nHicks, 2001, Pattern of uptake and excretion of 18F-FDG in the lactating breast, J. Nucl. Med., 42, 1238\nCrippa, 1998, Association between [18F]fluorodeoxyglucose uptake and prospective histology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation, Eur. J. Nucl. Med., 25, 1429, 10.1007\u002Fs002590050319\nAvril, 2001, Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis, J. Nucl. Med., 42, 9\nBos, 2002, Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography, J. Clin. Oncol., 20, 379, 10.1200\u002FJCO.20.2.379\nAvril, 2000, Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations, J. Clin. Oncol., 18, 3495, 10.1200\u002FJCO.2000.18.20.3495\nBakheet, 2000, F-18 FDG uptake in breast infection and inflammation, Clin. Nucl. Med., 25, 100, 10.1097\u002F00003072-200002000-00003\nAvril, 1997, Breast imaging fluorine-18-FDG PET: quantitative image analysis, J. Nucl. Med., 38, 1186\nHeinisch, 2003, Comparison of FDG-PET and dynamic contrast-enhanced MRI in the evaluation of suggestive breast lesions, Breast, 12, 17, 10.1016\u002FS0960-9776(02)00262-X\nSchirrmeister, 2001, Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures, Eur. J. Nucl. Med., 28, 351, 10.1007\u002Fs002590000448\nRosen, 2005, Detection of primary breast carcinoma with a dedicated, large-field-of view FDG PET mammography device: initial experience, Radiology, 234, 527, 10.1148\u002Fradiol.2342040654\nReznik, 2005, An amorphous selenium based positron emission mammography camera with avalanche gain, Technol. Cancer Res. Treat., 4, 61, 10.1177\u002F153303460500400109\nKim, 2005, Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstruel cycle, Eur. J. Nucl. Med. Mol. Imaging, 32, 757, 10.1007\u002Fs00259-005-1771-6\nLerman, 2004, Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET\u002FCT, J. Nucl. Med., 45, 266\nKurokawa, 2004, Expression of Glut-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of ovary, Int. J. Cancer, 109, 926, 10.1002\u002Fijc.20057\nCantuaria, 2000, Expression of Glut-1 glucose in borderline and malignant epithelial tumors of the ovary, Gynecol. Oncol., 79, 33, 10.1006\u002Fgyno.2000.5910\nKawahara, 2004, Evaluation of positron emission tomography with tracer 18-fluorodeoxyglucose in addition to magnetic resonance imaging in the diagnosis of ovarian cancer in selected women after ultrasonography, J. Comput. Assist. Tomogr., 28, 505, 10.1097\u002F00004728-200407000-00011\nRieber, 2001, Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings, AJR Am. J. Roentgenol., 177, 123, 10.2214\u002Fajr.177.1.1770123\nKoyama, 2003, Evaluation of 18F-FDG with bladder irrigation in patients with uterine and ovarian tumors, J. Nucl. Med., 44, 353\nNishizawa, 2005, Physiological 18F-FDG uptake in ovaries and uterus of healthy female volunteers, Eur. J. Nucl. Med. Mol. Imaging, 32, 549, 10.1007\u002Fs00259-004-1703-x\nYen, 2004, 18F-FDG uptake in squamous cell carcinoma of the cervix is correled with glucose transporter 1 expression, J. Nucl. Med., 45, 22\nCarter, 1989, Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases, Cancer, 63, 181, 10.1002\u002F1097-0142(19890101)63:1\u003C181::AID-CNCR2820630129>3.0.CO;2-H\nBarranger, 2003, Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer, Ann. Surg. Oncol., 10, 622, 10.1245\u002FASO.2003.12.019\nFehr, 2004, Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy, Breast J., 10, 89, 10.1111\u002Fj.1075-122X.2004.21455.x\nDanforth, 2002, The role of 18F-FDG in the local\u002Fregional evaluation of women with breast cancer, Breast Cancer Res. Treat., 75, 135, 10.1023\u002FA:1019664126220\nWahl, 2004, Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET study group, J. Clin. Oncol., 22, 277, 10.1200\u002FJCO.2004.04.148\nEubank, 2001, 18-Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer, J. Clin. Oncol., 19, 3516, 10.1200\u002FJCO.2001.19.15.3516\nBellon, 2004, Evaluation of internal mammary lymph nodes by FDG-PET in locally breast cancer (LABC), Am. J. Clin. Oncol., 27, 407, 10.1097\u002F01.coc.0000128869.19357.9b\nKinkel, 2002, Detection of metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis, Radiology, 224, 748, 10.1148\u002Fradiol.2243011362\nKurtaran, 2000, 18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver, Liver, 20, 487, 10.1034\u002Fj.1600-0676.2000.020006487.x\nMoon, 1998, Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma, J. Nucl. Med., 39, 431\nOtha, 2001, Whole body PET for the evaluation of bony metastases in patients with 99mTc-MDP bone scintigraphy, Nucl. Med. Commun., 22, 875, 10.1097\u002F00006231-200108000-00005\nYang, 2002, Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer, J. Cancer Res. Clin. Oncol., 128, 325, 10.1007\u002Fs00432-002-0342-5\nCook, 1998, Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions, J. Clin. Oncol., 16, 3375, 10.1200\u002FJCO.1998.16.10.3375\nUematsu, 2005, Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer, AJR Am. J. Roentgenol., 184, 1266, 10.2214\u002Fajr.184.4.01841266\nVan der Hoeven, 2004, 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography in staging of locally advanced breast cancer, J. Clin. Oncol., 22, 1253, 10.1200\u002FJCO.2004.07.058\nYoshida, 2004, Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer, AJR Am. J. Roentgenol., 182, 227, 10.2214\u002Fajr.182.1.1820227\nReinhardt, 2001, Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET, Radiology, 218, 766, 10.1148\u002Fradiology.218.3.r01mr19776\nFollen, 2003, Imaging in cervical cancer, Cancer, 98, 2028, 10.1002\u002Fcncr.11679\nBarranger, 2004, Technique et intérêt potentiel de la détection du ganglion sentinelle dans le cancer utérin, Méd. Nucl., 28, 305\nResbeut, 2003, Standards, options, recommandations : cancers invasifs du col utérin stades non métastatiques (version abrégée), Bull. Cancer, 90, 333\nBrémond, 2002, Standards, options et recommandations 2000 : cancer de l'endomètre, stades non métastatiques (rapport abrégé), Bull. Cancer, 89, 697\nBerman, 1984, Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecology Oncology Group study), Gynecol. Oncol., 19, 8, 10.1016\u002F0090-8258(84)90151-3\nPark, 2005, The usefulness of IRM and PET imaging for the detection of parametrial involment and lymph node metastasis in patients with cervical cancer, Jpn. J. Clin. Oncol., 35, 260, 10.1093\u002Fjjco\u002Fhyi079\nBelhocine, 2002, Contribution of whole-body 18FDG PET imaging in the management of cervical cancer, Gynecol. Oncol., 87, 90, 10.1006\u002Fgyno.2002.6769\nNarayan, 2001, A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment, Int. J. Gynecol. Cancer, 11, 263, 10.1046\u002Fj.1525-1438.2001.011004263.x\nLin, 2003, Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings, Gynecol. Oncol., 89, 73, 10.1016\u002FS0090-8258(03)00058-1\nGrigsby, 2001, Lymph node staging by positron emission tomography in patients with carcinoma of the cervix, J. Clin. Oncol., 19, 3745, 10.1200\u002FJCO.2001.19.17.3745\nHorowitz, 2004, Prospective evaluation of FDG-PET for detection pelvic and para-aortic lymph node metastasis in uterine corpus cancer, Gynecol. Oncol., 95, 546, 10.1016\u002Fj.ygyno.2004.08.009\nTran, 2003, Occult supraclavicular lymph node metastasis identified by FDG-PET in patient with carcinoma of the uterine cervix, Gynecol. Oncol., 90, 572, 10.1016\u002FS0090-8258(03)00402-5\nEubank, 1998, Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy, AJR Am. J. Roentgenol., 171, 1103, 10.2214\u002Fajr.171.4.9763005\nNemoto, 1980, Management and survival of female breast cancer: results of a national survey by the American College of Surgeons, Cancer, 45, 2917, 10.1002\u002F1097-0142(19800615)45:12\u003C2917::AID-CNCR2820451203>3.0.CO;2-M\nGiven, 2000, The predictive of tumor markers CA 15-3, TPS and CEA in breast cancer recurrence, Breast, 9, 277, 10.1054\u002Fbrst.1999.0154\nGrahek, 2004, [18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management, Eur. J. Nucl. Med., 31, 179, 10.1007\u002Fs00259-003-1348-1\nSuarez, 2002, Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers, Q. J. Nucl. Med., 46, 113\nLonneux, 2000, The place of whole body PET FDG for the diagnosis of distant recurrence of breast cancer, Clin. Positron Imaging, 3, 45, 10.1016\u002FS1095-0397(00)00042-X\nGoerres, 2003, Follow-up of women with breast cancer: comparison between MRI and FDG PET, Eur. Radiol., 13, 1635, 10.1007\u002Fs00330-002-1720-8\nvan Oost, 2004, Staging in patients with locoregional recurrent breast cancer: current practice and prospects for positron emission tomography, Eur. J. Cancer, 40, 1545, 10.1016\u002Fj.ejca.2004.03.012\nGallowitsch, 2003, F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging, Invest. Radiol., 38, 250, 10.1097\u002F01.RLI.0000063983.86229.f2\nZang, 2000, Impact of secondary cytoreduction surgery on survival of patients with advanced epithelial ovarian cancer, Eur. J. Surg. Oncol., 26, 789, 10.1053\u002Fejso.2000.1007\nTorizuka, 2002, Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose, Eur. J. Nucl. Med., 29, 797, 10.1007\u002Fs00259-001-0750-9\nChang, 2002, Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumor marker, Neoplasma, 49, 329\nBristow, 2003, Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET\u002FCT, Gynecol. Oncol., 90, 519, 10.1016\u002FS0090-8258(03)00336-6\nNanni, 2005, 18F-FDG PET\u002FCT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients, Eur. J. Surg. Oncol., 31, 792, 10.1016\u002Fj.ejso.2005.02.029\nMenzel, 2004, The influence of CA125 and CEA levels on the results of (18)F-deoxyglucose positron emission tomography in suspected recurrence of epithelial ovarian cancer, Strahlenther. Onkol., 180, 497, 10.1007\u002Fs00066-004-1208-3\nPannu, 2004, PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation, Abdom. Imaging, 39, 398\nBristow, 2005, Combined PET\u002FCT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes, Gynecol. Oncol., 99, 294, 10.1016\u002Fj.ygyno.2005.06.019\nRiuz-Hernandez, 2005, Impact of positron emission tomography with FDG-PET in treatment of patients with suspected recurrent ovarian cancer, Rev. Esp. Med. Nucl., 24, 113\nNakamoto, 2002, Pronostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy, Gynecol. Oncol., 84, 289, 10.1006\u002Fgyno.2001.6504\nUnger, 2004, Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women, Gynecol. Oncol., 94, 212, 10.1016\u002Fj.ygyno.2004.04.021\nRyu, 2003, Detection of early recurrence with 18F-FDG PET in patients with cervical cancer, J. Nucl. Med., 44, 347\nMaiman, 1993, Squamous cell carcinoma antigen in serum for monitoring of head and neck and uterine cervical squamous cell carcinoma after radiotherapy, Acta Oncol., 32, 663, 10.3109\u002F02841869309092449\nChang, 2004, Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies, Cancer, 101, 164, 10.1002\u002Fcncr.20349\nPark, 2000, Diagnosis of recurrent uterine cervical cancer: computed tomography versus positron emission tomography, Korean J. Radiol., 1, 51, 10.3348\u002Fkjr.2000.1.1.51\nYen, 2003, Value of dual-phase 2-fluoro-2-deoxy-D-glucose positron emission tomography in cervical cancer, J. Clin. Oncol., 21, 3651, 10.1200\u002FJCO.2003.01.102\nYen, 2004, Defining the priority of using 18F-FDG PET for recurrent cervical cancer, J. Nucl. Med., 45, 1632\nBelhocine, 2002, Usefulness of 18F-FDG PET in the post-therapy surveillance of endometrial carcinoma, Eur. J. Nucl. Med., 29, 1132, 10.1007\u002Fs00259-002-0878-2\nOshida, 1998, Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoror[18F]-D-glucose, Cancer, 82, 2227, 10.1002\u002F(SICI)1097-0142(19980601)82:11\u003C2227::AID-CNCR18>3.0.CO;2-W\nInoue, 2004, Preoperative evaluation of prognosis in breast cancer patients by [18F]2-deoxy-2-fluoro-D-glucose-positron emission tomography, J. Cancer Res. Clin. Oncol., 130, 273, 10.1007\u002Fs00432-003-0536-5\nMankoff, 2002, Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy, J. Nucl. Med., 43, 500\nDose Schwarz, 2005, Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET, J. Nucl. Med., 46, 1144\nSchelling, 2000, Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer, J. Clin. Oncol., 18, 1689, 10.1200\u002FJCO.2000.18.8.1689\nSmith, 2000, Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy, J. Clin. Oncol., 18, 1676, 10.1200\u002FJCO.2000.18.8.1676\nChen, 2004, Combined use MRI and PET to monitoring response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy, Acad. Radiol., 11, 1115, 10.1016\u002Fj.acra.2004.07.007\nVranjesevic, 2002, Whole-body 18F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients, J. Nucl. Med., 43, 325\nMortimer, 2001, Metabolic flare: indicator of hormone responsiveness in advanced breast cancer, J. Clin. Oncol., 19, 2797, 10.1200\u002FJCO.2001.19.11.2797\nMorris, 1992, What are the benefits of routine breast cancer follow-up?, Postgrad. Med., 68, 904, 10.1136\u002Fpgmj.68.805.904\nVogel, 1995, Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer, J. Clin. Oncol., 13, 1123, 10.1200\u002FJCO.1995.13.5.1123\nSchneider, 1994, Flare on bone scintigraphy following Taxol chemotherapy for metastastic breast cancer, J. Nucl. Med., 35, 1748\nStafford, 2002, Use of serial FDG PET to mesure the response of bone-dominant breast cancer to therapy, Acad. Radiol., 9, 913, 10.1016\u002FS1076-6332(03)80461-0\nSijmons, 2000, Second-look and second surgery: second chance or second best?, Semin. Surg. Oncol., 19, 54, 10.1002\u002F1098-2388(200007\u002F08)19:1\u003C54::AID-SSU9>3.0.CO;2-9\nSironi, 2004, Integrated FDG PET\u002FCT in patients with persistent ovarian cancer: correlation with histologic findings, Radiology, 233, 433, 10.1148\u002Fradiol.2332031800\nRose, 2001, Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy, Gynecol. Oncol., 82, 17, 10.1006\u002Fgyno.2001.6246\nKim, 2004, [18F]FDG PET as a substitute for second look laparotomy in patients with advanced ovarian carcinoma, Eur. J. Nucl. Med. Mol. Imaging, 31, 196, 10.1007\u002Fs00259-003-1367-y\nZimny, 2001, 2-[fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer, Gynecol. Oncol., 83, 310, 10.1006\u002Fgyno.2001.6386\nYoshida, 2004, Metabolic monitoring of advanced uterine cervical cancer neoadjuvant chemotherapy by using [F-18]-fluorodeoxyglucose positron emission tomography: preliminary results in three patients, Gynecol. Oncol., 95, 597, 10.1016\u002Fj.ygyno.2004.08.037\nTsai, 2004, Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI\u002FCT, Int. J. Radiat. Oncol. Biol. Phys., 58, 1506, 10.1016\u002Fj.ijrobp.2003.09.013\nGrigsby, 2005, Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET, Int. J. Radiat. Oncol. Biol. Phys., 61, 444, 10.1016\u002Fj.ijrobp.2004.05.046\nGrigsby, 2004, Lymph node control in cervical cancer, Int. J. Radiat. Oncol. Biol. Phys., 59, 706, 10.1016\u002Fj.ijrobp.2003.12.038\nGrigsby, 2004, Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome, J. Clin. Oncol., 22, 2167, 10.1200\u002FJCO.2004.09.035",{"ES":1454},"Contribución de la tomografía por emisión de positrones con fluorodesoxiglucosa (18F) en las pacientes afectadas de cáncer genital o mamario",{"VOID":1456},"10.1016\u002Fs1283-081x(06)47735-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X06477353",[1459,1473,1488,1500,1512],{"id":1460,"sortIndex":114,"researcher":26,"roles":1461,"affiliations":1462,"properties":1471},"3ba7b276-82fc-41fa-a9dc-5354cd83adf0",[681],[1463],{"id":26,"sortIndex":36,"affiliation":1464,"properties":26},{"id":1465,"createTime":1466,"updateTime":1466,"relativeEntities":1467,"slug":26,"properties":1468,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"c80a299c-8c5b-4e3a-a5c1-417c02048ad6","2023-12-23T06:11:29.649+00:00",[],{"title":1469},{"VI":1470},"Service de gynécologie obstétrique, Hôpital Tenon, 4, rue de la Chine, 75020 Paris France",{"title":1472},{"VI":819},{"id":1474,"sortIndex":36,"researcher":26,"roles":1475,"affiliations":1476,"properties":1485},"e4842113-801c-45fc-b06d-028cd515fc24",[681],[1477],{"id":26,"sortIndex":36,"affiliation":1478,"properties":26},{"id":1479,"createTime":1480,"updateTime":1480,"relativeEntities":1481,"slug":26,"properties":1482,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"5f77f196-0b94-4eff-8210-6c09adfe8e54","2024-01-08T10:49:26.208+00:00",[],{"title":1483},{"VI":1484},"Centre TEP et service de médecine nucléaire, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France",{"title":1486},{"VI":1487},"D. Grahek",{"id":1489,"sortIndex":111,"researcher":26,"roles":1490,"affiliations":1491,"properties":1497},"5a1d9758-0ec3-41d5-991e-4bfa5e183f76",[681],[1492],{"id":26,"sortIndex":36,"affiliation":1493,"properties":26},{"id":1479,"createTime":1480,"updateTime":1480,"relativeEntities":1494,"slug":26,"properties":1495,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1496},{"VI":1484},{"title":1498},{"VI":1499},"J.-N. Talbot",{"id":1501,"sortIndex":115,"researcher":26,"roles":1502,"affiliations":1503,"properties":1509},"29ab6308-ea8c-4855-9eba-1f3478549f46",[681],[1504],{"id":26,"sortIndex":36,"affiliation":1505,"properties":26},{"id":1465,"createTime":1466,"updateTime":1466,"relativeEntities":1506,"slug":26,"properties":1507,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1508},{"VI":1470},{"title":1510},{"VI":1511},"E. Barranger",{"id":1513,"sortIndex":59,"researcher":26,"roles":1514,"affiliations":1515,"properties":1521},"05154dc5-2a8b-446c-bba4-c71599268d3d",[681],[1516],{"id":26,"sortIndex":36,"affiliation":1517,"properties":26},{"id":1465,"createTime":1466,"updateTime":1466,"relativeEntities":1518,"slug":26,"properties":1519,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1520},{"VI":1470},{"title":1522},{"VI":1523},"S. Uzan",{"url":1457,"publisher":1525,"properties":1533},{"id":735,"createTime":736,"updateTime":736,"relativeEntities":1526,"slug":738,"properties":1527,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1530,"manageAffiliations":1531,"indexDatabases":1532,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1528,"title":1529},{"VOID":741},{"EN":743},[],[],[],{"volume":1534,"pages":1536},{"VOID":1535},"42",{"VOID":1537},"1-15","2006-01-01",2006,{"code":1541,"data":1542,"meta":26},"SUCCESS",{"id":735,"createTime":736,"updateTime":736,"relativeEntities":1543,"slug":738,"properties":1544,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1547,"manageAffiliations":1548,"indexDatabases":1549,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1545,"title":1546},{"VOID":741},{"EN":743},[],[],[]]